The Global Health Program for Fellows and Scholars provides supportive mentorship, research opportunities and a collaborative research environment for early stage investigators from the U.S. and low- and middle-income countries (LMICs), as defined by the World Bank, to enhance their global health research expertise and their careers. Five Consortia (funded in part by the Fogarty Interna- tional Center [FIC] through competitive grants) identify postdoctoral Fellows and doctoral Scholars:

Global Health Equity Scholars (GHES) University of California, Berkeley Florida International University Stanford University Yale University

UCGHI GloCal Health Fellowship Program UC San Francisco UC San Diego UC Los Angeles UC Davis

The UJMT Fogarty Global Health Fellowship Consortium The University of North Carolina-Chapel Hill Johns Hopkins University Morehouse School of Medicine Tulane University

The Northern/Pacific Global Health Research Fellows Training Consortium (NPGH) University of Washington University of Hawaii University of Michigan University of Minnesota

The VECD Consortium Vanderbilt University Emory University Cornell University Duke University

The following NIH Institutes, Centers and Offices are collaborating with Fogarty on this program:

▪ Eunice Kennedy Shriver National Institute of Child Health and ▪ National Institute of Diabetes and Digestive and Kidney Diseases Human Development (NICHD) (NIDDK) ▪ National Cancer Institute (NCI) ▪ National Institute on Drug Abuse (NIDA) ▪ National Eye Institute (NEI) ▪ National Institute of General Medical Sciences (NIGMS) ▪ National Heart, Lung, and Blood Institute (NHLBI) ▪ National Institute of Mental Health (NIMH) ▪ National Institute of Allergy and Infectious Diseases (NIAID) ▪ National Institute of Neurological Disorders and Stroke (NINDS) ▪ National Institute of Arthritis and Musculoskeletal and Skin ▪ National Institute of Nursing Research (NINR) Diseases (NIAMS) ▪ Office of AIDS Research (OAR) ▪ National Institute of Biomedical Imaging and Bioengineering ▪ Office of Research on Women’s Health (ORWH) (NIBIB) ▪ Office of Behavioral and Social Sciences Research (OBSSR) ▪ National Institute of Dental and Craniofacial Research (NIDCR)

Fulbright-Fogarty Awards in Public Health Fulbright-Fogarty Grants: Postdoctoral Research Grants in Public Health

Fulbright-Fogarty Awards offered in partnership between the Fulbright Program and FIC have been established to promote the ex- pansion of research in public health and clinical research in resource-limited settings. The Fulbright-Fogarty Fellowship was inaugu- rated in July 2011 with four Fellows in Sub-Saharan Africa. All awards are for nine months at the overseas site. Awards will carry the benefits of Fulbright Study/Research Grants to the country of assignment.

Fulbright-Fogarty U.S. scholar grants have been newly established to promote post-doctoral research in public health in resource- limited settings. Grantees conduct current research at sites affiliated with the FIC. Fulbright grants will fund nine months of research in seven of eight countries; in the ninth, Fulbright grants will fund four months and FIC will seek to arrange funding for the remain- ing five months. Scholars who received their PhD or other appropriate terminal degree within the past five years are eligible to apply.

The Global Health Program for Fellows and Scholars is based on the success and 2experience of the Fogarty International Clinical Research Scholars and Fellows (FICRS-F) Program. Global Health Equity Scholars (GHES) Fellowship Program Program Description 5 Year 2 Trainees 6

UCGHI GloCal Health Fellowship Program Program Description 11 Year 2 Trainees 12

UJMT Fogarty Global Health Fellowship Program Program Description 17 Year 2 Trainees 18

Northern/Pacific Global Health (NPGH) Fellowship Program Program Description 25 Year 2 Trainees 26

VECD Fellowship Program Program Description 35 Year 2 Trainees 36

Alumni Speakers GHES 45 GloCal 48 UJMT 50 NPGH 51 VECD 53

Trainee Index GHF and Fulbright-Fogarty Year 2 Trainees 55 GHF and Fulbright-Fogarty Alumni Speakers 60

*Global Health Program: “Fellows” are post-doctoral trainees; “Scholars” are doctoral degree candidates Fulbright-Fogarty Awards & Grants: “Scholars” are post-doctoral trainees; “Students” are doctoral degree candidates

3 4 The Global Health Equity Scholar (GHES) program brings together a consortium that includes the Uni- versity of California, Berkeley; Florida International University; Stanford University and Yale Univer- sity; and 19 affiliated international sites across 16 countries (Bangladesh, Brazil, China, Colombia, Ethiopia, India, Kenya, Malaysia, Nicaragua, Peru, Russia, South Africa, Trinidad and Tobago, Uganda, Ukraine and Zimbabwe). The main objective of the program is to generate a new and young cadre of global health researchers, educators, and professionals who will be prepared to address the new challenges in global health. These may include health challenges that arise from the world's burgeoning human settlements, known as slums, that have developed in urban and rural communities of many low- and middle-income countries. Factors associated with chronic, non-communicable, as well as infectious diseases, environmental health hazards, risks specific to women and children, intentional and unintentional injuries, and mental disor- ders are potential areas of research that will be supported under this program. Additionally, the program will support research on the challenges of providing accessible and high quality health care services at all levels in resource-limited settings. Interventions that seek to address the management of scarce re- sources and identify innovative solutions to improving health services, and the evaluation of these inter- ventions, will be supported under this program.

UCB Director: Lee W. Riley, MD Professor of Epidemiology & Infectious Diseases Chair, Division of Infectious Diseases & Vaccinology

FIU Director: Purnima Madhivanan, MBBS, MPH, PhD Associate Professor of Epidemiology

Stanford Director: Michele Barry, MD, FACP Professor of Medicine

Yale Director: Albert Icksang Ko, MD Associate Professor of Epidemiology and Medicine

Program Assistant Director: Melaine Delcroix, PhD: [email protected] Stanford Program Manager: Nancy A. Federspiel, PhD: [email protected]

5 BANGLADESH

Dr. Hoy-Schulz will spend her fellowship year at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) in Dhaka, under the mentorship of Julie Par- sonnet, MD. Her research will focus on testing two probiotic strains in infants in Bangla- desh to confirm safety and determine the microbiological, immunological, and clinical effects. Her long term goal is to determine the possibility of probiotics as an inexpensive, sustainable intervention to prevent malnutrition and stunting.

Dr. Hoy-Schulz earned her BS from Yale University where she studied utilizing commen- sal microbes to prevent disease and researched Chagas disease in Guatemala. She then earned her PhD from Stanford University and received an NSF Graduate Research Fel- lowship. Her thesis work examined the effect of Salmonella infection on microbiota and Yana Emmy health. She is currently an infectious diseases / epidemiology postdoc and pursuing a Mas- HOY-SCHULZ, PhD ter’s degree in epidemiology. Dr. Hoy-Schulz has had a long-standing interest in global U.S. Fellow health, epidemiology, and microbiology. Her long-term career goal is to study the global prevention of diarrheal disease and malnutrition in infants and children.

Dr. Rojas will spend his fellowship year at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) in Dhaka, under the mentorship of K.C. Huang, PhD. His research will focus on examining the diversity of interepidemic reservoirs of Vibrio cholera.

Dr. Rojas’ broad career goal is to apply ideas from engineering, physics, and computer science to health related problems in microbiology. He first became interested in applying physical principles to biology at the University of Pennsylvania, where he designed a pro- totype solid-state biosensor for thyroid hormone. During graduate school he transitioned into cell biophysics, studying the mechanics of cell growth in plants. After his PhD, Dr. Rojas spent six months as a volunteer faculty at the Patan Academy of Health Sciences in Enrique ROJAS, PhD Patan, Nepal, where he taught medically relevant chemistry, biology and physics to first- U.S. Fellow year medical students. BRAZIL

Dr. Marlow will spend her fellowship year at Federal University Fluminense in Rio de Janiero, under the mentorship of Lee Riley, MD. Her research will assess the baseline incidence of drug-resistant community-acquired infections, the genotype distribution of MRSA isolates, and drug-resistance genes of these MRSA isolated from children attend- ing day care centers and their family members in the urban slums of Rio De Janeiro before the World Cup and the Olympics.

Dr. Marlow received her PhD from the Federal University of Santa Catarina, Brazil, in- vestigating the molecular epidemiology of leishmaniasis. While obtaining her MPH from The George Washington University, she conducted research with the NHBS Study and the DC DOH. During this time, she received the Practicum Research Fellowship Award to Mariel MARLOW, perform research at ICDDR,B in Bangladesh. Dr. Marlow’s postdoctoral research will PhD, MPH focus on investigating health outcomes in Brazilian urban slums in preparation for the U.S. Fellow upcoming World Cup and World Olympics. Her career goals center on becoming a global health leader in the field of infectious disease molecular epidemiology.

6 Dr. Paploski will spend his fellowship year at Fundação Oswaldo Cruz (FIOCRUZ) in Salvador, under the mentorship of Guilherme de Sousa Ribeiro, MD, MSc, PhD. His re- search will focus on determining the prevalence of people previously infected with den- gue, determine the incidence of asymptomatic and clinical dengue infection, and to pro- spectively identify individual and environmental risk factors for dengue infection in epi- demic and inter-epidemic periods, based on the follow-up of a cohort and a surveillance for acute febrile illness in a community health care center.

Dr. Paploski earned his DVM from Federal University of Paraná, in southern Brazil; he worked with zoonosis prevention, especially with the prevention of rabies transmitted by bats in human populations. He started his MSc in Epidemiology at FIOCRUZ in early Igor PAPLOSKI, 2011, where he studied the risk for clinical progression of leptospirosis in an urban slum. DVM, MSc He earned his MSc degree in early 2013 and is now a PhD candidate in Public Health at LMIC Fellow Federal University of Bahia. Dr. Paploski studies dengue and is interested in studying the epidemiology of diseases that disproportionally affect neglected populations. ETHIOPIA

Mr. Shen will spend his fellowship year at Addis Ababa University in Addis Ababa, under the mentorship of Elizabeth Bradley, PhD. His research is entitled Learning about the self, from others: A study of hospital quality improvement in the Ethiopian Hospital Alliance for Quality. The aim of the proposed study is to examine the relationship between hospi- tals' participation in a quality alliance and their performance, as mediated by continuous quality improvement adoption.

Mr. Shen is a doctoral candidate in the health services and policy analysis PhD program at the University of California, Berkeley. His doctoral training is in Organization Theory, which is being applied in a dissertation titled “Institutionalization of deinstitutionalization: Gordon SHEN, SM A cross-national analysis of mental health policy diffusion and regulatory gap.” He has U.S. Fellow also designed and administered academic research and World Health Organization- commissioned consulting projects in the United States, China, Palestine, Romania, and India. These qualifications and experiences, cumulatively, make Mr. Shen particularly well-suited to lead the proposed project on hospital alliance in Ethiopia. INDIA

Mr. Cybulski will spend his fellowship year at Public Health Research Institute of India (PHRII) in Mysore, under the mentorship of Manu Prakash, PhD. His research will pro- vide design evaluation, revisions, and field data for the efficacy of ultra-low cost micro- scope technology. The Foldscope, which can provide over 2,000X magnification with submicron resolution for less than a dollar in parts, will be compared against current diag- nostic tools in the field to determine the most promising applications for its implementa- tion.

Mr. Cybulski earned BS degrees in Mechanical Engineering and Physics from Lehigh University in 2002, a MS degree in Mechanical Engineering from MIT in 2004, and is James CYBULSKI, currently pursuing a PhD in Mechanical Engineering at Stanford University. He worked MS for Intel Corporation in Chandler, AZ from 2004-2005 and was co-founder and CTO of U.S. Scholar two medical device startup companies during 2008-2011. His current research concerns the development of an ultra-low cost microscope for disease diagnostics and education. Mr. Cybulski was the recipient of an NSF fellowship and his work is currently supported in part by the Gates Foundation. 7 Dr. Puttaswamy will spend his fellowship year at Sri Ramachandra Medical University in Chennai, under the mentorship of Kalpana Balakrishnan, PhD. His research will focus on health risk assessment of pregnant women and children exposed to polycyclic aromatic hydrocarbons from household air pollution.

Dr. Puttaswamy is currently working as a scientist in the Department of Environmental Health Engineering, Sri Ramachandra University (EHE-SRU), India. He received his PhD in Environmental Toxicology from the University of Saskatchewan in 2011. Following this, he was awarded a NSERC fellowship to work at the NRCan, Ottawa. In 2012, he joined Prof. Kalpana Balakrishnan’s research team at the EHE-SRU. The growing burden of disease due to air pollution in India has motivated Dr. Puttaswamy to pursue a research Naveen career in environmental epidemiology. He is interested in applying toxicological and bio- PUTTASWAMY, analytical techniques in environmental health research. PhD, MSc LMIC Fellow PERU

Dr. Cyrus will spend her fellowship year at the Asociación Civil Impacta Salud y Educa- ción (IMPACTA) in Lima, under the mentorship of Purnima Madhivanan, MD, MPH and Frederick Altice, MD, MA. Her research will focus on secondary data analysis on a longi- tudinal survey—specifically on sexual risk behavior among transgender individuals in Lima.

During her doctoral training at FIU, Dr. Cyrus worked at an NCMHD Center of Excel- lence mentored by Drs. Mary Jo Trepka and Mario De La Rosa—her dissertation focused on social capital, HIV risk behavior and substance-use among Latino immigrants. She worked with FHI360 on microbicide trials and completed the University of Michigan Elena CYRUS, PhD, Population Fellowship at EngenderHealth/Ghana. Dr. Cyrus published, and presented at MPH conferences including: Caribbean Health Research Scientific Council, Triangulating on U.S. Fellow Health Equity in the Caribbean, American Public Health Association, and Coalition for Advancing Multipurpose Innovations. She aims to become a global health researcher on sexual risk behavior and women's health. UKRAINE

Dr. Polonsky will spend his fellowship year at the Ukrainian Institute on Public Health Policy in Kyiv, under the mentorship of Frederick L. Altice, MD, MA. His research will focus on developing and introducing social marketing strategies to reverse the negative attitudes about opioid substitution therapy (OST), and educe behavioral change towards OST acceptance and sustainability for Ukrainian providers and patients alike.

Dr. Polonsky’s career goal is to be an independent researcher at the interface of social marketing, consumer psychology, and public health. Dr. Polonsky received his PhD in Marketing and Consumer Behavior, as well as a complimentary graduate certificate in quantitative research methods in psychology, that reinforces his interdisciplinary orienta- Maxim POLONSKY, tion. As a PhD candidate he was awarded the School of Business Outstanding PhD Stu- PhD dent Scholar Award, a program-wide recognition that is given to one PhD student each U.S. Fellow year. His research resulted in several publications, national and international conference presentations, and invited lectures.

8 9 10 The UCGHI GloCal Health Fellowship Program is managed and supported by the University of Califor- nia Global Health Institute (UCGHI). UCGHI supports interdisciplinary research and training across the UC campus network. As a UC-wide initiative, UCGHI focuses on producing leaders and practitioners of global health, conducting innovative and relevant research, and developing international collaborations to improve the health of vulnerable people and communities around the world. UC's strength in a range of disciplines such as veterinary medicine, pharmacy, nursing, health sciences, oceanography and eco- nomics gives the UCGHI GloCal Health Fellowship Program a vast and unique research portfolio that is used to train the next generation of global health researchers.

The UCGHI GloCal Health Fellowship Program includes four UCs from the UCGHI (UC San Fran- cisco, UC San Diego, UC Los Angeles, and UC Davis), as well as international partners who are out- standing research institutions based in 14 low- and middle-income countries including: Bangladesh, Bra- zil, Chile, China, Ethiopia, India, Kenya, Mexico, Mozambique, Panama, Peru, Uganda, Ukraine, and Zimbabwe. All sites have been conducting federally-supported research and training for at least three years, have published extensively in major journals and are committed to training the next generation of global health researchers from within their own country as well as the program's collaborating UC cam- puses.

UCSF Director: Craig Cohen, MD, MPH Co-Director, UCGHI Center of Expertise in Women's Health and Empowerment

UCSD Director: Steffanie Strathdee, PhD Associate Dean of Global Health Sciences Chief, Division of Global Public Health

UCLA Director: Thomas Coates, PhD Director, Program in Global Health

UCD Director: Patricia Conrad, PhD, DVM Professor, Pathology, Microbiology & Immunology

Program Manager: Kimberly Bale, MPH: [email protected]

11 INDIA

Dr. Kundu will spend her fellowship year at the All India Institute of Medical Sciences (AIIMS) in New Delhi, under the mentorship of Woutrina Miller, DVM, MPVM, PhD and Sanjeev Sinha, MD. Her research will focus on investigating the water-borne illnesses in developing countries using molecular techniques and risk assessment approach, specifi- cally, to characterize the source of fecal contamination in polluted water bodies with the help of real time qPCR. This will help identify the sources of fecal pollution in water bod- ies in India. This research has two significant attributes—Microbial source tracking (MST) and Quantitative microbial risk assessment (QMRA)—that have not been applied in many developing country settings.

Dr. Kundu’s dissertation research focused on estimating health risks from enteric patho- Arti KUNDU, gens in environmental matrices. She has been involved with national and international PhD, MEng research as she has pursued her passion for a career in public health. These experiences U.S. Fellow have given her a solid motivation as a researcher and inspired her to make a difference in the world by doing more health-related research. As a result of these multi-cultural experi- ences, she is aware of the importance of One Health research in a developing country. Her career aspiration is to work with an international organization serving developing coun- tries to improve human health.

Dr. Radhakrishna will spend his fellowship year at St. John's Research Institute in Ban- galore, under the mentorship of Tony D.S. Raj, MD; Sriram Sampath, MD and Maria Ekstrand, PhD. His research will focus on designing and developing low-cost, technol- ogy-driven solutions to monitor hand hygiene compliance among healthcare workers. This project is a proof of concept, and the expected outcomes involve a decrease in the number of healthcare-associated infections in the critical/high dependency areas of a hos- pital.

Dr. Radhakrishna's objective is to identify areas of deficiency in healthcare delivery in resource-constrained settings and build collaborative programs to develop innovative, low-cost technologies to bring about a shift in the delivery of healthcare. He considers Kedar himself an informaticist trying to bridge the medical and technological worlds. His major RADHAKRISHNA, influence has been his mentor, Dr. Tony Raj. Dr. Radhakrishna’s Android application PhD, MBBS, MPhil won a prize at the national level that will be pre-installed on one of India's low-cost An- LMIC Fellow droid tablets. He was also one of the lead coordinators for the "National Health Portal" by the Ministry of Health, Government of India. KENYA

Dr. Bailey will spend his fellowship year at Kenya Medical Research Institute (KEMRI) and Organic Health Response (OHR) on Mfangano Island, under the mentorship of Craig Cohen, MD, MPH; Elizabeth Bukusi, MBChB, MMed, MPH, PhD, PGD and Brandon Brown, PhD. His research will focus on the characterization of changes in health behavior, perception, and environmental risk factors following a total sanitation intervention in rural Kenya.

Dr. Bailey is focused on investigating environmental health problems associated with wa- ter, sanitation, and air quality. After completing his PhD in Environmental Engineering at the University of California Irvine, Dr. Bailey completed a Master of Public Health to Morgan Michael bridge his technical training and environmental background with the health field. Dr. Bai- BAILEY, PhD, MPH ley has since investigated environmental health issues around the globe and has focused U.S. Fellow on using a multi-disciplinary approach to explore some of the world’s most pressing health problems. 12 Dr. Syvertsen will spend her fellowship year at Kenya Medical Research Institute (KEMRI) and Impact Development & Research Organization (IRDO) in Kisumu, under the mentorship of Carol Camlin, PhD, MPH; Kawango Agot, PhD, MPH and Steffanie Strathdee, PhD. Her research will focus on combining ethnographic fieldwork with epide- miologic surveys and in-depth interviews to examine the emergent phenomenon of injec- tion drug use in Nyanza Province, Kenya, and identify risks for drug-related health harms including HIV, Hepatitis, abscesses, and fatal overdose.

Dr. Syvertsen has been with UCSD since 2009, working on a study of HIV/STI risk among female sex workers and their non-commercial partners along the Mexico-U.S. bor- der (PI: Steffanie Strathdee). Her fieldwork experiences in Tijuana and the mentorship she Jennifer SYVERTSEN, has received at UCSD have profoundly shaped her career. Dr. Syvertsen's publications PhD, MPH have appeared in Culture, Health & Sexuality and Social Science & Medicine. She has U.S. Fellow accepted a faculty position in the Department of Anthropology at Ohio State University to begin in 2014. At OSU, she will pursue NIH funding to continue researching injection drug use in Kenya.

MEXICO

Mr. Pinedo will spend his fellowship year at Health Frontiers in Tijuana Clinic in Tijuana, under the mentorship of Victoria Ojeda, PhD, MPH; Jose Luis Burgos, MD, MPH and Gudelia Rangel, PhD. His research will employ mixed methods to better understand and examine correlates of circular migration and HIV risk behaviors in communities of origin among migrants currently residing in Tijuana, Mexico.

Mr. Pinedo is a doctoral student in Global Public Health at the University of California, San Diego. He previously earned his MPH from the UC Berkeley in Health and Social Behavior. Mr. Pinedo has contributed to various investigations and publications related to the health of migrant populations in the U.S. and Latin America. As a doctoral student, he has been the recipient of the AIDS International Training Research Fellowship and has Miguel PINEDO, MPH conducted research on migration, substance use, and HIV risk perception among Mexican U.S. Scholar migrants. His current research project will investigate circular migration and HIV trans- mission in Mexico.

Dr. Servin will spend her fellowship year at El Colegio de la Frontera Norte in Tijuana, Baja California, under the mentorship of Jay G. Silverman, PhD and Gudelia Rangel, PhD. Her research will focus on assessing the intersecting epidemic of second-generation sex work, drug use and risk for HIV in the U.S.-Mexico border context and to develop and implement evidence based prevention interventions targeting vulnerable populations such as female sex workers (FSWs), injection drug users (IDUs) and their children.

Dr. Servin’s goal is to become an independent investigator in HIV prevention among vul- nerable populations in the U.S.-Mexico border region, specifically, understanding the so- cial factors affecting development of substance abuse and entry to sex work, and testing of Argentina SERVIN, behavioral interventions. Her career and personal influence has been her mother. Dr. MD, MPH Servin is a bilingual and bicultural clinician trained in preventive medicine, infectious U.S. Fellow disease and clinical epidemiology whose work includes working in multiple cities in Mex- ico and Central America assessing HIV education and health services utilization among populations at high risk for HIV, including FSWs, IDUs and persons living with HIV.

13 Dr. Urada will spend her fellowship year at El Colegio de la Frontera del Norte in Tijuana, under the mentorship of Anita Raj, PhD, Kimberly Brouwer, PhD and Gudelia Rangel, PhD. Her research, titled Mujeres Unidas (Women United), will focus on urgently investi- gating barriers and facilitators to community mobilization (a structural intervention mobi- lizing FSWs around their safety/human rights) in Tijuana, Mexico. Her project addresses a significant global health problem associated with HIV/STI transmission and substance use.

Dr. Urada’s research and career goal focuses on adapting structural interventions for fe- male sex workers (FSWs) to diverse global contexts. Her prior fieldwork in social welfare Lianne URADA, provided the groundwork for her current work. Funded by the UC Pacific Rim Research PhD, MSW Program, she led HIV prevention intervention research on 500 female bar/spa workers and U.S. Fellow their managers in the Philippines, collaborating with a multidisciplinary team. She also received a Fordham Research Ethics Training Institute grant to investigate the ethical con- duct of research of female sex workers. She has systematically attained research training in the past decade and has 13 relevant publications. MOZAMBIQUE

Dr. Rose will spend his fellowship year at Universidade Eduardo Mondlane in Maputo, under the mentorship of Stephen Bickler, MD and David Chang, PhD, MPH, MBA. His research will focus on implementing an innovative data-gathering protocol to monitor surgical outcomes in a resource-poor hospital setting in Mozambique and validate its abil- ity to predict risk-adjusted mortality. The intended outcome of this pilot project is to en- courage quality improvement in surgical care in low- and middle-income countries around the globe.

Dr. Rose is a resident physician in General Surgery aspiring to an academic career in health systems analysis to improve global health delivery. He has published multiple stud- ies aimed at increasing efficiency, reducing costs, and eliminating disparities to improve John ROSE, MD, MPH the quality of surgical care. While a medical student at UC Irvine, he evaluated the role of U.S. Fellow pelvic radiography in the American College of Surgeons’ Adult Trauma Life Support pro- tocol. During his MPH degree at the Harvard School of Public Health, he led a coalition of 1200 students to disseminate the WHO Safety Checklist in 14 countries.

PERU

Dr. Konda will spend her fellowship year at Universidad Peruana Cayetano Heredia (UPCH) in Lima, under the mentorship of Thomas J. Coates, PhD and Carlos Caceres, MD, PhD. Her research will focus on understanding and describing sexual relationships between gay men in Peru and determining if voluntary couples counseling and testing would be useful, feasible, and acceptable in the Peruvian context.

Dr. Konda’s career goal is to become an independent investigator designing and conduct- ing clinical trials of socially and culturally appropriate combination HIV prevention inter- ventions for MSM in Latin America. She has worked on HIV prevention research in Peru since 2004, becoming integrated into the local HIV prevention research community. Dr. Kelika KONDA, Konda’s interest in HIV prevention began while serving as a Peace Corps Volunteer in the PhD, MHS Dominican Republic. She then went on to complete a Master’s in International Health and U.S. Fellow Social and Behavioral Interventions and then a PhD in Infectious Disease Epidemiology at Johns Hopkins Bloomberg School of Public Health.

14

Dr. Menacho will spend his fellowship year at Universidad Peruana Cayetano Heredia (UPCH) in Lima, under the mentorship of Patricia Garcia MD, MPH, PhD and Jesse Clark, MD, MSc. His research will focus on exploring bisexual men’s needs for sexual health and preferences for HIV/STIs interventions in Peru.

Dr. Menacho aims to become an expert on research related to HIV/STIs in high risk groups, such as men who have sex with men. Also, he wants to contribute to decreasing stigma and discrimination. He is motivated by testing unexplored approaches, like tech- nology-based interventions, to increase access to sexual health services for hidden popula- tions. Dr. Menacho obtained a Master’s in Public Health from the University of Washing- ton in 2010. In 2012, he completed a Fogarty Fellowship in clinical research through Luis MENACHO, which he studied the prevalence of anal cancer among Peruvian men who have sex with MD, MPH men. LMIC Fellow

UGANDA

Dr. Semeere will spend his fellowship year at the Infectious Diseases Institute in Kam- pala, under the mentorship of Jeffrey N. Martin, MD, MPH and Andrew Kambugu, MBChB, MMed. His research will focus on evaluating the epidemiology of Kaposi's sar- coma among adult HIV infected patients in the antiretroviral therapy (ART) era.

Dr. Semeere's ultimate goal is to become an African independent clinical investigator in- terested in chronic diseases, of which HIV and its complications are now becoming in the ART era. His motivation is the scarcity of well-trained, contemporary clinical researchers from the region. He has had specialized substantive clinical training in Uganda and the requisite clinical research skills from the University of California, San Francisco. These requisite research skills and context-specific clinical knowledge equip him adequately to not only handle research-specific tasks but also to, eventually, mentor and train others Aggrey S. SEMEERE, while translating findings into clinical practice. MBChB, MMed, MAS LMIC Fellow

15 16 The UJMT Fogarty Global Health Fellowship Consortium provides a new opportunity in global health research training for selected junior faculty, fellows, and scholars. This global health fellowship program offers 11 months of mentored clinical research training for pre- and postdoctoral candidates.

Based in over 20 years of research and training collaboration, this consortium brings together 19 primary research training sites in Africa, Asia and South America. There are 59 U.S.-based mentors across the universities’ disciplines in medicine, public health, and the basic sciences. Seventy-six specified in- country faculty mentors are available across the international sites, many of whom were trained through Fogarty International Center programs.

UNC Director: Charles van der Horst, MD Professor, Medicine Associate Chief, Division of Infectious Diseases Director, UNC Center for AIDS Research Developmental Core

JHU Director: Yukari Manabe, MD Associate Professor, Medicine

MSM Director: Kofi Kondwani, PhD Asst. Professor, Community Health and Preventive Medicine Founding Chair and Member, Global Health Task Force

MSM Co-Director: Jonathan K. Stiles, PhD Professor, Microbiology, Biochemistry and Immunology Director, Postdoctoral Training Program in Genomics and Hemoglobinopathies

TU Director: Pierre Buekens, MD, PhD Dean, School of Public Health and Tropical Medicine Director, Office of Global Health

TU Co-Director: Geetha Bansal, PhD Assoc. Dean for Research, School of Public Health & Tropical Medicine

UJMT Program Manager: Kathryn Salisbury, MPH: [email protected]

17 ARGENTINA

Dr. Weaver will spend her fellowship year at Instituto de Efectividad Clínica y Sanitaria in Buenos Aires, under the mentorship of Pierre Buekens, MD, PhD. Her research will focus on evaluating changes in referral patterns for health care clinics receiving an emer- gency obstetric quality improvement intervention.

Dr. Weaver's program of research focuses on evaluating interventions that aim to improve the quality of and access to reproductive health services in low-resource settings. She is currently analyzing methods of measuring maternal mortality using Verbal Autopsy in Africa and South Asia and will expand this research portfolio through a Fogarty Global Health Fellowship in Argentina. Dr. Weaver's interests evolved from her work evaluating Emily WEAVER, a national level midwifery program in Indonesia and personal experiences. She earned her PhD, MA PhD in Health Policy and Management from UNC in 2011 and completed a Postdoctoral U.S. Fellow Fellowship in 2011. CHINA

Dr. Hall will spend his fellowship year at UNC-Project China/Sun Yet Sen University in Guangzhou, under the mentorship of Joe Tucker, MD, MA. His research will focus on evaluating the effect of social networks of African migrants on mental health and sub- stance abuse outcomes.

Dr. Hall’s broad interest in the mental health consequences of adversity and identifying social factors that protect health, along with the influence of his excellent research men- tors, shaped his goal to become an independently funded global mental health researcher. He aims to concentrate his career focus in Asia, and China specifically. Dr. Hall has been the recipient of the NIH Loan Repayment Program for Clinical Research and the Lillian Friedman Award (Kent State University). Brian HALL, PhD, MA U.S. Fellow

Dr. Hu will spend her fellowship year at Guangzhou 8th Hospital in Guangzhou, under the mentorship of Stanley Lemon, MD. Her research will focus on investigating Hepatitis B virus (HBV) resistant variants or drug resistant strains being transmitted among HIV in- fected patients before 3TC is used and after 8 years of 3TC in HAART, as well as HBV resistant variants’ evolution during HAART with 3TC in HIV/HBV co-infected patients in South China. Ultra-deep sequencing method will be involved in this project to determine the NRTIs resistant variants of HBV.

After her PhD training, Dr. Hu started her research work focusing on HIV/AIDS at Guangzhou 8th Hospital, an infectious disease hospital in South China. In November 2011, she began her postdoctoral fellowship in Infectious Diseases at UNC, supported by Fengyu HU, MD, PhD both UNC and Guangzhou 8th Hospital. Dr. Hu’s career goals include improving infec- LMIC Fellow tious diseases research in China and utilizing greater international collaboration in the investigation of HIV/AIDS and other infectious diseases.

18 Ms. Sivasubramiam will spend her fellowship year at the Cancer Institute and Hospital- Chinese Academy of Medical Sciences in Beijing, under the mentorship of Jennifer S. Smith, PhD and You-Lin Qiao, MD, PhD, MPH. Her research will focus on a clinical trial -based integrated study of breast cancer screening in China. She will go to Beijing to take part in the creation of a government-supported national screening program.

Ms. Sivasubramiam is a fourth-year medical student at Vanderbilt University School of Medicine. She is interested in a combined surgery and oncology residency, ultimately going into an academic research career in pediatric surgery or surgical oncology.

Priya SIVASUBRAMANIAM U.S. Scholar GHANA

Mr. Ashimolowo will spend his fellowship year at University of Ghana Medical School in Accra, under the mentorship of Jonathan Stiles, PhD. His research will focus on determin- ing the significance of cxcl10 and micro RNA levels and how it relates to the disease se- verity in pre-treatment and post-treatment phases of malaria.

Mr. Ashimolowo is currently on the Hank and Yvonne Thomas merit honors scholarship at Morehouse School of Medicine. He is still undecided about which specialty of medicine he would like to practice. He is very interested in surgery. Hopefully in about 20 years, he will be able to work for an international health organization.

Tolu ASHIMOLOWO U.S. Scholar

Dr. Driss will spend his fellowship year at University of Ghana School of Medicine in Accra, under the mentorship of Jonathan Stiles, PhD. His research will focus on identify- ing genetic polymorphisms associated with malaria severity in sickle cell compared to non -sickle cell patients in Ghana.

Dr. Driss has been involved in a broad range of scientific projects in several outstanding research centers throughout the world. He always had key roles in very important interna- tional collaborations between different laboratories. This international experience ac- quainted him in communication and integration with different cultures. Dr. Driss’ research interests aim to use genomic approaches to identify functional gene variations and poly- Adel DRISS, morphisms that can be used as biomarkers for different phenotypes and on different popu- PhD, MSc lations. He also has interests in teaching and supervising the future generation of research- U.S. Fellow ers.

Mr. Li will spend his fellowship year at Akosombo Hospital in Akosombo, under the mentorship of Jonathan Stiles, PhD. His research will focus on analyzing protein and mi- croRNA markers people to see if polymorphisms alter susceptibility to disease.

Mr. Li is a third year medical student at Morehouse School of Medicine in Atlanta, GA with an interest in pediatrics and international health. His goals are to one day work for a global health organization like the WHO or UNICEF. Mr. Li's greatest accomplishment was working for a year as a full time mentor for kids in under-served schools of LA. Hopefully his future accomplishments will have a similar trend of promoting positive changes in the world. Duo LI U.S. Scholar 19 MALAWI

Dr. Jagger will spend her fellowship year at UNC Project-Malawi in Lilongwe, under the mentorship of Irving Hoffman, PA, MPH. Her research will focus on examining the rela- tionship between exposure to household air pollution from biomass burning and the inci- dence of tuberculosis in peri-urban Malawi. The study is a community-based case-control design.

Dr. Jagger is an assistant professor in Public Policy/Environment and Ecology at UNC- CH, and a faculty fellow at the Carolina Population Center. Her research focuses on the welfare impacts of natural resource management policies in developing countries. Dr. Jag- ger has a K01 Mentored Research Scientist Award from NICHD to study the population, Pamela JAGGER, land use and health dynamics of biomass fuel use in sub-Saharan Africa. Her aim is to PhD, MSc integrate health outcome data into the analysis of welfare outcomes associated with bio- U.S. Fellow mass fuel dependence. She has previously worked at the World Bank and the International Food Policy Research Institute.

Ms. Kohler will spend her fellowship year at UNC Project-Malawi in Lilongwe, under the mentorship of Satish Gopal, MD, MPH. Her research examines current knowledge, atti- tudes/beliefs, and preferences regarding breast cancer and early detection among women in Malawi. The project will focus on understanding what women know and value about breast health care in order to develop culturally-relevant and sustainable breast cancer interventions. This is Ms. Kohler’s dissertation research

Ms. Kohler is a Health Policy and Management doctoral student at UNC. She is interested in cancer outcomes research as it pertains to health disparities in low- and middle-income countries, specifically breast and cervical cancer prevention and control. Ms. Kohler’s Raquel “Kelly” research has included analyzing Medicaid claims data of breast cancer patients, and mod- KOHLER, MSPH eling health and economic outcomes of treatment strategies for head and neck cancer and U.S. Scholar gastric cancer. Ms. Kohler’s goal is to become a skilled investigator who identifies cancer disparities and uses data to develop culturally-relevant interventions to improve cancer care access and outcomes for underserved populations.

Ms. Lancaster will spend her fellowship year at UNC Project-Malawi in Lilongwe, under the mentorship of William Miller, MD, MPH, PhD. Her research will focus on assessing alcohol use disorders as a barrier to HIV engagement into care and treatment among fe- male sex workers in Lilongwe, Malawi.

Ms. Lancaster hopes to have a career in academic research as an independently funded epidemiologist focused on the social, behavioral, and structural determinants of HIV/STIs in resource limited settings. Her exposure to global public health research began while working in a Peruvian parasitology laboratory. She pursued her MPH in Epidemiology at Tulane University, continuing her interests in global health. Upon finishing her degree, she worked at FHI360 as a Global Health Research Fellow, a two-year “traineeship” in a Kathryn variety of scientific and operational activities. Ms. Lancaster will complete her PhD train- LANCASTER, MPH ing in Epidemiology at the University of North Carolina. U.S. Scholar

20 Dr. Ongubo will spend his fellowship year at UNC Project-Malawi in Lilongwe, under the mentorship of Mina Hossienipour, MD, MPH and Jeff Wilkinson, MD. His research will focus on PMTCT option B+ (universal ART eligibility for all pregnant women for life) roll-out in Malawi and evaluation of the effects of ART exposure on neurodevelopment of HIV-exposed infants and young children.

Most young physicians working in developing countries feel dissatisfied in their perform- ance because of inadequate skills in managing population health. Evidence based medi- cine has since overtaken anecdotal, or even empirical evidence. With HIV/AIDS and other communicable and noncommunicable diseases having reached pandemic levels, popula- tion-based health management emerged crucial in especially resource limited settings. Dennis ONGUBO, Such reality motivated Dr. Ongubo to pursue training in global health research in commu- MBChB nicable diseases and neglected tropical infections. His career goals include enhancing con- U.S. Fellow tinuous quality improvement in public health practice through pharmacovigilance and training of health professionals and future researchers in developing countries.

Ms. O’Shea will spend her fellowship year at UNC Project-Malawi in Lilongwe, under the mentorship of Mina Hosseinipour MD, MPH. Her research will focus on the evaluation of family planning knowledge, perceptions, and uptake of long-acting reversible contracep- tives among postpartum HIV+ and HIV- Malawian women.

Ms. O'Shea is an MD/MPH candidate at the University of Arizona College of Medicine. Prior research experiences include epidemiology of diarrheal disease in Costa Rica as an intern with the Costa Rican health department and a study of perceptions of intellectual disability in Lima, Peru. Her interest in women's health was motivated by her involvement with the Refugee Women's Health Clinic at the Maricopa county health center in Phoenix, Arizona. She plans to graduate with a degree in medicine and public health and complete Michele O’SHEA her medical training for a career in global health with a focus on women's health. Fulbright-Fogarty Stu- dent

PERU

Dr. Deshotel will spend his fellowship year at the Tulane Health Office for Latin America in Lima, under the mentorship of Nirbhay Kumar, PhD. His research will focus on identi- fying the most prevalent antigenic amino acid sequences for use in the development of a malaria transmission blocking vaccine.

Dr. Deshotel has worked on vaccines aimed at preventing tuberculosis, Hansen's Disease, tularemia, and malaria. His observations while working with these diverse pathogens have led him to focus on vaccine design in an effort to produce the appropriate immune re- sponse. His long term goals are to remain in academia while focusing on the development of DNA vaccine scaffolds that are both prophylactic and therapeutic.

Michael DESHOTEL, PhD U.S. Fellow

21 RWANDA

Dr. Kozycki will spend her fellowship year at National University of Rwanda in Kigali, under the mentorship of Don Krogstad, MD. Her research will focus on estimating the frequency of false-negative rapid diagnostic tests (RDTs) among febrile children present- ing to CHWs.

Dr. Kozycki is a second year resident in the Internal Medicine and Pediatrics program at Tulane. She earned her undergraduate degree from Georgia Tech and her MD from the Medical College of Georgia. She was introduced to the challenges of malaria control as a medical student, first as an intern with the Zanzibar Malaria Control Program and later as an epidemiology elective student at the CDC. She also earned her Master's from the Har- vard School of Public Health. She is now excited about the opportunity to continue build- Christina KOZYCKI, ing on her experiences under the guidance of her mentor, Dr. Krogstad. MD, MPH U.S. Fellow

SOUTH AFRICA

Dr. Hansoti will spend her fellowship year at the University of Cape Town (UCT), under the mentorship of Lee Wallis, MBChB, MD. Her research will focus on the implementa- tion of the WHO Emergency Triage Assessment and Treatment (ETAT) tool in primary healthcare centers in low resource settings.

Dr. Hansoti is currently a fellow in International Emergency Medicine and Public Health as well as a clinical instructor within the department of Emergency Medicine at the Johns Hopkins School of Medicine. Over the last several years, she has provided direct clinical care in India, Ghana, Jamaica, China and Nepal. During her MPH, she elected to focus primarily on epidemiology and biostatistics to improve her research skills. Dr. Hansoti’s career goal is to improve clinical outcomes research in the global health setting and use Bhakti HANSOTI, these findings to improve evidence based practice in low- and middle-income resource MBChB, MPH U.S. Fellow

Dr. Paich will spend her fellowship year at the University of Cape Town (UCT), under the mentorship of Graeme Meintjes, PhD. Her research will focus on investigating the effects of antiretroviral therapy-associated metabolic dysfunction and alterations in the immune response to tuberculosis and influenza in peripheral blood mononuclear cells from HIV+ individuals who are healthy weight, overweight, and obese.

Dr. Paich’s ultimate career goal is to conduct meaningful, collaborative, translational re- search addressing serious public health challenges, in addition to instructing and mentor- ing undergraduate and graduate students in a tenure-track faculty position. Specifically, she is interested in studying obesity-associated chronic diseases and conditions, such as Heather PAICH, PhD diabetes and heart disease, using methods that have traditionally been used to study immu- U.S. Fellow nology and infectious disease, including flow cytometry. Dr. Paich is a 2012 recipient of the American Society of Nutrition’s McNeil Nutritionals Predoctoral Fellowship Award and has published a number of first author manuscripts.

22 UGANDA

Dr. Lee will spend her fellowship year at the Infectious Diseases Institute (IDI), Makerere University in Kampala, under the mentorship of Allison Agwu, MD, ScM. Her research is an observational study to characterize and assess individual-level and clinic-level features associated with optimal HIV clinical outcomes, rates of ART adherence, retention in care, and utilization of services for youth (ages 16-24 years) living with HIV enrolled in care at a youth-only transition clinic compared to youth and adults (≥25 years) attending a gen- eral adult clinic in Kampala, Uganda. Additionally, this project aims to qualitatively ex- plore youth preferences and expectations regarding youth-friendly clinic features that may assist with adherence and retention in care, and youth satisfaction and acceptability of current available services at the youth-only and general adult clinical sites. Lana LEE, MD U.S. Fellow Dr. Lee is currently an Adolescent Medicine fellow at the Johns Hopkins School of Medi- cine. She has a long-standing commitment to global health and previously spent 18 months in rural South Africa as an HIV medical provider for children and adults. Dr. Lee’s research focus is to understand the multi-level barriers to health for vulnerable ado- lescents and young adults, particularly those living with HIV, to inform effective interven- tions designed to improve health outcomes during this important period of the lifecourse. She graduated from the University of Illinois School of Medicine and completed her Medicine-Pediatrics residency training at Yale-New Haven Hospital.

23 24 The Northern/Pacific Global Health Research Fellows Training Consortium is a partnership between the Universities of Washington, Hawaii, Michigan and Minnesota; with international partnerships in Kenya, Uganda, Cameroon, Ghana, Peru, Thailand and China. These institutions were chosen due to our strong collaborative history and our existing NIH training grant programs; together we have over 200 years of collaboration with the seven international partners in our consortium.

Research and training themes currently addressed by Consortium members range across a wide spectrum of health themes, including infectious diseases (HIV, malaria, tuberculosis, herpesviruses, HPV, HTLV), key non-communicable and chronic health problems (cancer, pulmonary and cardiovascular disease, child development and mental health, women’s health, genetics, and nutrition), environmental (built en- vironment, tobacco use, lead toxicity, slum upgrading), trauma, policy, nursing, oral health, engineering and implementation science – making these Consortium partnerships ideal locations to mentor trainees from a wide variety of disciplines and provide an interdisciplinary training environment for the next gen- eration of Global Health researchers.

Director: Joseph Zunt, MD, MPH Associate Director, International Core, Center for AIDS Research (CFAR) Co-Director, Program in Education and Research in Latin America (PERLA)

Co-Director: Vivek R. Nerurkar, DMLT, MSc, PhD Chair, Department of Tropical Medicine, Medical Microbiology and Pharmacology (TMMMP) Director, Technical Core, Centers for Biomedical Research Excellence (COBRE), Pacific Center for Emerging Infectious Diseases Research (PCEIDR), NCRR, NIH

Co-Director: Joseph C. Kolars, MD Senior Associate Dean of Education and Global Initiatives

Co-Director: Chandy John, MD, MS Director, Division of Global Pediatrics

Program Manager: Nicole Hobbs: [email protected]

25 CAMEROON

Dr. Achonduh will spend her fellowship year at Biotechnology Centre, University of Yaoundé 1 in Yaoundé, under the mentorship of Diane W. Taylor, PhD and Rose Leke, PhD. Her research will focus on infection pyrogen profiles (malaria, salmonella, rubella, meningitis) of children ages 0-15 years old.

Dr. Anchonduh has been a clinical monitor and trainer for the World Health Organization as well as a consultant for the Clinton Health Access Initiative. She received her Masters of Philosophy degree from the University of Ghana and a Bachelors degree from the Uni- versity of Bueau, Cameroon in Biochemistry.

Olivia ACHONDUH, PhD, MPhil LMIC Fellow

Dr. Babakhanyan will spend her fellowship year at Biotechnology Centre, University of Yaoundé 1 in Yaoundé, under the mentorship of Rose Leke, PhD (Cameroon) and Diane W. Taylor, PhD (University of Hawaii). Her research will focus on the role of monocytes in HIV and placental malaria co-infections.

Dr. Babakhanyan’s goal is to become a professor, to inspire and train a new generation of scientists, and to conduct translational research in international consortia settings. Throughout her career, Dr. Babakhanyan was greatly influenced by her PhD mentor, who has developed a malaria diagnostic test and conducts international research. In addition, during a prior stay in Cameroon, Dr. Babakhanyan was moved by endemic deprivation and the juxtaposition of this poverty with the opportunities available to her. Thus, she Anna hopes to capitalize on her unique training in biotechnology and infectious diseases, and BABAKHANYAN, hopes to bring innovative solutions to improve health care in developing countries. PhD, MBT U.S. Fellow GHANA

Dr. Oteng will spend his fellowship year at Komfo Anokye Teaching Hospital in Kumasi, under the mentorship of Ronald Maid, MD. His research will focus on creating, imple- menting and analyzing a trauma registry similar to the one used by the American Acad- emy of Surgery; and will also perform and compare preventable death statistics between Ghana and similar populations in the U.S.

Dr. Oteng is a Ghanaian-born, U.S.-trained emergency physician who is the lead clinician in the first ED in sub-Saharan Africa outside of South Africa. He had been exposed to several one-sided north-south collaborations that typically left the southern partner at a deficit. He believes the way to impart sustainable systems changes that will begin to ad- dress the enormous needs in Africa is to build local capacity. Dr. Oteng’s aim is to prove Rockefeller OTENG, his assertion that we can provide improved outcomes in our global relationships that will MD start to improve baseline conditions in the lives of our partners in developing countries. U.S. Fellow

26 KENYA

Mr. Ayieko will spend his fellowship year at Maseno University in Nairobi, under the mentorship of Chandy John, MD, MS. His research will focus on the effect of reduced malaria transmission on immune responses to common childhood vaccines.

Mr. Ayieko developed an interest in infectious diseases while growing up in western Kenya, where both malaria and HIV are highly prevalent. His long-term goal is to become a research scientist in immunology of infectious diseases, thereby contributing to finding a solution to the malaria and HIV problem in Kenya. At the same time, he also serves as an assistant lecturer at Maseno University, where he is involved in teaching and mentoring of undergraduate students. Cyrus AYIEKO, MSc LMIC Scholar

Dr. Chivatsi will spend his fellowship year at Oloolua Forest Institute of Primate Research in Nairobi, under the mentorship of Jason Bell, MD, MPH, MS. His research will focus on the development of a non-human primate (baboon) model for human alphapapilloma virus infection.

Dr. Chivatsi earned his Bachelor of Veterinary Medicine and Master of Science in Veteri- nary Pathology and Diagnostics from University of Nairobi, Nairobi, Kenya. He is cur- rently a senior veterinary pathologist at the Institute of Primate Research, Nairobi, Kenya. His research interests lie in reproductive disease in non-human primates, which includes endometriosis, chlamydia and papilloma virus. His career goals are to register for a PhD at University of Nairobi and continue with his research interests. Dr. Chivatsi has over 40 Daniel Chai publications with several collaborators from Kenya, the U.S. and Europe. He has worked CHIVATSI, at Yerkes and California Primate Centers. DVM, MSc LMIC Fellow

Ms. Hamre will spend her fellowship year at Kenya Medical Research Institute (KEMRI) in Kisumu, under the mentorship of Chandy John, MD, MS. Her research will focus on the epidemiology of malaria in the highland areas of Kapsisiywa and Kipsamoite, Kenya - areas of unstable transmission prone to epidemics. In these areas, researchers from the University of Minnesota and KEMRI reported evidence of local malaria transmission in- terruption from April 2007–March 2008. Using anthropogenic, demographic, entomo- logic, environmental, and spatial factor data, she intends to study the epidemiology of malaria across time and transmission patterns in the same study population and location while making comparisons of predictors of malaria risk before and after interruption of transmission.

Karen HAMRE, MPH Ms. Hamre is an Epidemiology doctoral student at the University of Minnesota and works U.S. Scholar as Data Manager for Dr. Chandy John's studies focusing on the immunoepidemiology of malaria. While completing her MPH in Biostatistics and Epidemiology at Boston Univer- sity, she supplemented major coursework with international health electives and focused her research on the importance of Nigeria in polio eradication efforts. Between schooling, Ms. Hamre worked at the contract research organization Westat working on domestic studies related to health topics ranging from reproductive to occupational health. Ms. Hamre returned to academia deliberately to focus on her career in global health.

27 Dr. Irungu will spend her fellowship year at the University of Nairobi in Thika, under the mentorship of Jared Baeten, MD, PhD. Her research will focus on determining the feasi- bility, screen-to-enroll ratio, and cost of using the risk scoring tool to enroll higher-risk HIV-1 serodiscordant couples into a demonstration project of pre-exposure prophylaxis (PrEP) and ART for HIV-1 prevention (Partners PrEP Demonstration Project); as well as determining HIV-1 incidence among HIV-1 uninfected partners enrolled in the demonstra- tion project.

Dr. Irungu is the deputy site coordinator for the UW collaborative Partners in Prevention (PrEP) Demonstration Project at the Thika Site, Kenya. Prior to joining this team she worked as a medical officer in a rural district in Kenya. She obtained her medical training Elizabeth IRUNGU, from the University of Nairobi and her MPH in Epidemiology from the University of MBChB, MPH Washington. Her research interests lie in HIV prevention and treatment, especially among LMIC Fellow HIV discordant couples in Sub-Saharan Africa. She is working towards developing into an independent investigator and pursuing a rewarding career in epidemiology.

Dr. Ton will spend his fellowship year at the University of Nairobi in Nairobi, under the mentorship of Carey Farquhar, MD, MPH. His research will focus on expanding partner notification (ePS) to increase engagement in HIV care.

Dr. Ton is an Infectious Disease Fellow at the University of Washington. While at UC, Berkeley and the University of Minnesota, he conducted research on MDR-TB in Peru, worked in a clinic in rural Haiti and coordinated HIV training workshops in Vietnam. In Nairobi, he implemented a study on measles revaccination among HIV-positive children. He has also been assessing HIV drug resistance in Nairobi utilizing a low-cost assay. Dr. Ton will return to Kenya to examine the effects of enhanced partner notification of HIV on engagement in care. He hopes to establish an independent research and clinical career. Quy TON, MD, MPH U.S. Fellow

PERU

Ms. Aharon will spend her fellowship year at Universidad Nacional Mayor de San Marcos (UNMSM) in Lima, under the mentorship of Joseph Zunt, MD, MPH. Her research will focus on assessing rates and barriers to follow-up of abnormal pap smears among Lima's commercial sex worker population through interviews and focus groups.

Ms. Aharon is currently a medical student at Mount Sinai School of Medicine. She gradu- ated with a degree in Political Science from Columbia University, and hopes to combine her interests in policy and medicine through a career in global health. She developed a passion for women’s health issues through counseling survivors of sexual assault and pro- ducing Mount Sinai’s The Vagina Monologues. She is also interested in community-based Devora AHARON change, and has worked to expand access to care for uninsured patients through Mount U.S. Scholar Sinai’s student-run free clinic. Ms. Aharon hopes to explore her passion for women’s and community health through her research in Lima.

28 Ms. Deichsel will spend her fellowship year at Universidad Nacional Mayor de San Mar- cos in Lima, under the mentorship of Joseph Zunt, MD. Her research will focus on inves- tigating burden and manifestations of Human T-lymphotropic virus (HTLV) in Peru.

Ms. Deichsel earned her Master’s in Public Health in Epidemiology from the UCLA Fielding School of Public Health. Prior to the Master’s degree, Ms. Deichsel spent time in Tanzania and the Dominican Republic working with HIV positive women to prevent verti- cal transmission and improve general health. She is interested in women's health, infec- tious diseases, and vertical transmission. Ms. Deichsel plans to pursue a PhD in Epidemi- ology focused on infectious diseases and women's health following the Fulbright-Fogarty Fellowship. Emily DEICHSEL, MPH Fulbright-Fogarty Student

Ms. Heitzinger will spend her fellowship year at Universidad Nacional Mayor de San Marcos (UNMSM) in Lima, under the mentorship of Silvia M. Montano, MD, MPH. Her research will focus on conducting a cross-sectional study aimed at improving diarrhea treatment and prevention in the Peruvian Amazon.

Ms. Heitzinger earned her MPH from the University of Washington and is currently pur- suing a PhD in epidemiology at the same institution. She is interested in conducting re- search on technologies to prevent and treat diarrhea in the developing world. She is cur- rently collaborating with the U.S. Naval Medical Research Unit No. 6 in Peru to complete her PhD dissertation, reporting the results of a randomized trial of interventions to im- Kristen prove household drinking water quality in the rural Ica region. She intends to pursue a HEITZINGER, MPH future career involving global health research and capacity building. U.S. Scholar

Dr. Ma will spend her fellowship year at Universidad Nacional de Mayor de San Marcos (UNMSM) in Lima, under the mentorship of Jorge Alarcón, MD, PhD, MPH and Javier Lama, MD, MPH. Her research will focus on establishing a neurosyphilis diagnostic clinic for testing patient cerebrospinal fluid (CSF) within the Institute of Tropical Medicine at UNMSM, and identifying Treponema pallidum bacterial strains prevalent in syphilis pa- tients in Lima (collaboration with IMPACTA-Peru).

Dr. Ma earned her doctorate in Immunology from the University of Washington where she conducted basic research in innate immune regulation of adaptive immune responses dur- ing viral infections. Her work with West Nile virus prompted her to pursue a career in Daphne MA, PhD infectious disease. The HHMI Molecular Medicine Training Program, which awarded her U.S. Fellow a training scholarship, also provided her relevant training for translational research of hu- man diseases. As infectious disease is a global health problem, Dr. Ma hopes to use her immunology background to direct research for surveillance, vaccine and therapy develop- ment for managing infectious diseases in a global health context.

29 Ms. Metcalf will spend her fellowship year at the U.S. Naval Medical Research Institute No.6 (NAMRU-6) in Lima, under the mentorship of Joseph R. Zunt, MD, MPH. Her re- search will focus on an evaluation of diagnostic techniques in presumptive Tuberculous meningitis patients with and without HIV infection.

Ms. Metcalf currently resides in Lima and is working on her PhD dissertation at NAMRU- 6. Her research interests are focused on the immunological response to Tuberculous men- ingitis and evaluating current laboratory diagnostics. As a doctoral student at Mahidol University’s Bangkok School of Tropical Medicine, Ms. Metcalf studied clinical tropical medicine. She holds a Master of Science in Public Health and Tropical Medicine with a Tatiana METCALF, concentration in Parasitology from Tulane University, as well as dual Bachelor of Science MSPH degrees in Cellular & Molecular Biology and in Kinesiology. U.S. Scholar

Dr. Mori will spend his fellowship year at Universidad Nacional Mayor de San Marcos (UNMSM) in Lima, under the mentorship of Silvia Montano, MD. His research will focus on comparing the cytokine profile and neurological outcome in HTLV-1 carriers coin- fected with helminths with that in HTLV-1 carriers not coinfected with helminths.

Dr. Mori is a neurologist at Daniel A. Carrion Hospital and a study coordinator for the research protocol “Meningoencephalitis in Peru.” As research coordinator for a national multicenter study, he has learned a great deal about the different aspects of a multicenter study and gained expertise as an overseas researcher. His current goal is to conduct neu- roepidemiological studies of HTLV-1/2 infection in areas with limited access to health Nicanor MORI, care systems. His long-term career goal is to become an expert in neuroepidemiology both MD, MPH in Peru and internationally, specifically related to chronic neurological infections and un- LMIC Fellow derserved populations in Peru.

Dr. Nielsen will spend her fellowship year at Instituto Nacional de Salud de Niño in Lima, under the mentorship of Joseph Zunt, MD. Her research will focus on early warning scores. Early warning scores identify hospitalized children at high risk of clinical deterio- ration, and identification of these patients reduces the incidence of in-hospital cardiac ar- rest. Implementation of early warning scores in the emergency department has the poten- tial to identify children at high risk of deterioration, and using them to triage patients to different levels of care has the potential to improve overall outcomes.

Dr. Nielsen had her first global health experience as a medical student at the University of Iowa, where she spent five weeks in Cochabamba, Bolivia working in a pediatric hospital. Katie NIELSEN, Subsequent experiences in El Salvador and Mozambique during her pediatric residency MD, MPH and pediatric critical care fellowship at the University of Washington shaped her current U.S. Fellow interest in improving the identification of children at high risk for clinical deterioration in low resource settings. She plans to obtain an academic position in pediatric critical care that will allow her to continue clinical research in this area.

30 Dr. Romanoff will spend her fellowship year at Hospital Regional de EsSalud in Huan- cayo, under the mentorship of Silvia M. Montano, MD, MPH. Her research will focus on comprehensively evaluating breast cancer screening in Huancayo, Peru, and barriers to its use. Education will be provided to reduce negative outcomes and improve survivability in the target population.

Dr. Romanoff will utilize the Fulbright-Fogarty Postdoctoral Award in Public Health to address global disparities in women’s access to breast cancer screening and treatment in Huancayo, Peru. Anya received an MD degree from New York University before training as a resident in General Surgery at Mount Sinai Medical Center in New York. She has been involved in multiple research endeavors throughout her career, presented at national Anya ROMANOFF, symposia and was honored with an award for excellence in teaching. Future plans include MD fellowship in Surgical Oncology or Breast Surgery with continued participation in interna- Fulbright-Fogarty Post- tional outreach and public health research. doctoral Scholar

THAILAND

Dr. Kelley will spend his fellowship year at Mahidol University and Armed Forces Re- search Institute of Medical Sciences in Bangkok, under the mentorship of Anon Srikiatkhachorn, MD. His research will focus on investigating markers for severe dengue disease (DHF/DSS) progression. Specific aims include identifying DHF/DSS-associated vascular endothelial cell permeability triggers, and characterizing DHF/DSS-associated monocyte/macrophage transendothelial cell migration potential.

Dr. Kelley's overarching career goal is to eliminate mosquito-borne diseases, namely den- gue fever and malaria. He has been influenced most powerfully by his experiences abroad James KELLEY, as a Peace Corps Volunteer in Samoa, a researcher in South Africa and a WHO technical PhD, MPH officer in the Philippines. In addition to his intimate experience with multinational commu- U.S. Fellow nities as an East West Center Education Fellow in Honolulu Hawaii, Dr. Kelley believes that the Fogarty GHF Program will provide an ideal avenue to develop important clinical research skills, mentoring training, and other global health competencies to excel as a global health expert.

Dr. Prathep will spend her fellowship year at Prince of Songkla University in Songkla, under the mentorship of Nakornchai Phuenpathum, MD and Hutcha Sriplung, MD. Her research will focus on adherence to 2007 Brain Trauma Foundation guidelines in Songklanagarind Hospital, Thailand. The outcomes (discharge outcome: mortality, Glas- gow Outcome Score [GOS], ICU/hospital length of stay) data will be abstracted.

Dr. Prathep’s career goals are to develop a significant research career in trauma anesthe- sia, focusing on clinical research while maintaining a balanced clinical practice. She’s been interested in trauma from the time she was a medical student through her anesthesia residency and now as staff taking care of trauma patients. These patients inspire her to Sumidtra PRATHEP, improve treatment. Dr. Prathep received funding from her Thai institution to work on re- MD search at the University of Washington. The Fogarty Global Health Fellowship will give LMIC Fellow her the opportunity for a research collaboration to develop scientific questions that will result in answers benefitting injured people.

31 UGANDA

Dr. Bahr will spend his fellowship year at Makerere University in Kampala, under the mentorship of David Boulware, MD, MPH. His research will focus on using the Gene Xpert assay in patients with suspected TB meningitis.

Dr. Bahr completed his MD and MA in Bioethics and Health Policy at Loyola University Chicago Stritch School of Medicine. He completed his Internal Medicine residency at the University of Minnesota in 2012 and served as Chief Resident the following academic year; he's recently started his Infectious Disease fellowship at the University of Minne- sota. He's worked closely with Dr. David Boulware throughout his residency on a number of projects related to Cryptococcal Meningitis and toxicities due to treatment of this con- Nathan BAHR, MD, dition. MA, CTROPMED U.S. Fellow

Dr. Ddungu will spend his fellowship year at Makerere University in Kampala, Uganda, under the mentorship of Corey Casper, MD, MPH. His research will focus on investigat- ing the optimal use of blood and platelet transfusion among cancer patients in Uganda.

Dr. Ddungu graduated from Makerere University. He is a fellow at the Fred Hutchinson Cancer Research Center working on his PhD focusing on supportive care interventions aimed at improving survival of patients with hematological malignancies in Uganda. He is also a consultant at the Uganda Cancer Institute, where he holds a number of clinical and administrative responsibilities. He is an Associate Clinical Professor (Adjunct) at McMas- ter University, Faculty of Health Sciences Department of Medicine. He has worked with palliative care organizations in Uganda and internationally. Dr. Ddungu is active in col- Henry DDUNGU, laborative clinical research and has published papers in referenced journals. MBChB, MMed LMIC Fellow

Dr. Williams will spend her fellowship year at Makerere University in Kampala, under the mentorship of Chandy John, MD, MD. Her research will focus on determining the preva- lence of severe malarial anemia among G6PD-deficient individuals and better defining which genotypes of G6PD deficiency confer protection against severe malarial anemia, as well as investigating the role of alterations in redox status in conferring protection to G6PD-deficient individuals.

Dr. Williams grew up in several African countries including Nigeria, Ethiopia, Niger and Togo. Her interest in international work was borne during these formative years. She re- ceived her BS in Biochemistry and Molecular Biology from Michigan State University and her MD cum laude from St. George’s University, Grenada. She completed her Pediat- Olatundun ric residency at the University of Minnesota. Her research interests include the pathobiol- WILLIAMS, MD ogy of benign hematologic diseases and the reduction of global disparities where the man- LMIC Fellow agement of these conditions is concerned. She will be beginning a fellowship in Pediatric Hematology/Oncology at Northwestern University in 2014.

32 33 34 The VECD Consortium comprises four outstanding institutions – Vanderbilt (V), Emory (E), Cornell (C), and Duke (D) – with decades-long global partnerships with premier LMIC research institutions in Africa, Asia, Latin America, and the Caribbean. Collectively, VECDor’s well-funded research portfolio encompasses diverse and complementary topics in all relevant communicable and non-communicable diseases. VECDor institutions and faculty have a long history of global engagement, investigative ac- complishment, and mentoring excellence, as demonstrated by high-impact global health discoveries by VECD trainees.

The VECD international partners are themselves outstanding research institutions based in both low- income (Haiti, Zambia, Kenya, Tanzania, Vietnam, Rwanda) and middle-income countries (Brazil, Mex- ico, China, India). All sites conduct NIH-supported research and training and have published extensively in major journals. The VECD Global Health Consortium represents 115 faculty members from our four U.S. Universities and international collaborating institutions who serve as potential mentors for fellows.

Director: Sten H. Vermund, MD, PhD Director, Vanderbilt Institute for Global Health (VIGH) Co-Director: Douglas C. Heimburger, MD, MS Associate Director for Education and Training, VIGH Co-Director: Xiao Ou Shu, MD, PhD Professor of Medicine, Division of Epidemiology

Director: Daniel Fitzgerald, MD Co-Director, Center for Global Health Co-Director: Warren D. Johnson, Jr., MD Director, Center for Global Health Co-Director: Jean Wm. Pape, MD Director, GHESKIO

Director: K. M. Venkat Narayan, MD, MSc, MBA Ruth and OC Hubert Professor of Global Health & Epidemiology Co-Director: Carlos del Rio, MD Chair, Department of Global Health Co-Director: Usha Ramakrishnan, PhD Director, T32 Doctoral program in Nutrition & Health Sciences

Director: Nathan Thielman, MD Director, Global Health Residency/Fellowship Pathway Co-Director: Eric J. Velazquez, MD Director, Echocardiography Labs & Cardiac Diagnostic Unit Co-Director: Kathleen Sikkema, PhD Professor of Psychology and Neuroscience 35 Director of Operations & Management: Catherine Lem Carothers, MPH: [email protected]

BRAZIL

Dr. Dupnik will spend her fellowship year at Federal University of Rio Grande do Norte in Natal, under the mentorship of Warren D. Johnson, MD. Her research will focus on investigating the immune reactions of Hansen's disease (leprosy).

Kathryn DUPNIK, MD U.S. Fellow

Ms. Odetunde will spend her fellowship year at Oswaldo Cruz Foundation/Brazilian Min- istry of Health in Salvador, Bahia, under the mentorship of Albert Ko, MD. Her research will focus on assessing the effect of rapid population growth in the slum communities of Salvador, on the development of infectious disease and other chronic health conditions in the community. The overall goal of the study is to determine how leptospire dynamics in rodent and environmental reservoirs, and climatic, structural and social determinants in slums, influence the epidemiology of human disease.

Ms. Odetunde is currently a third year medical student at the University of Kentucky Col- lege of Medicine (UKCOM). She has had various research training opportunities through Juliana ODETUNDE, UKCOM, American Medical Student Association (AMSA) Research Exchange, National MS Institute on Aging, NIH intramural research training program, and graduate school re- Fulbright-Fogarty Stu- search work. Ms. Odetunde has a strong interest in medicine, global health and commu- dent nity-based clinical research. Upon completion of her medical training Ms. Odetunde hopes to have a strong career in academic medicine and also pioneer her own research projects pertaining to community health in medically underserved communities around the world.

Mr. Schwebler will spend his fellowship year at Federal University of Bahia in Salvador, under the mentorship of Edgar M. Carvalho, MD, PhD. His research will focus on the innate immune response in cutaneous leishmaniasis and describe the regulation of the in- flammatory response through the analysis of skin-associated cytokines and monocyte/NK cell subsets.

Mr. Schwebler is an MD candidate at Weill Cornell Medical College. After graduating from medical school, he will pursue graduate medical education in Anesthesiology and/or Pediatrics. He intends to have a career focused on working internationally in resource- limited settings while conducting clinical and public health research. In past projects, Mr. Schwebler has studied the immunologic response to HIV/SIV vaccines. His other research Kristopher interests include leishmaniasis, neglected tropical diseases, critical care medicine, health SCHWEBLER policy, and health systems. His career decisions and research interests are grounded in a Fulbright-Fogarty Stu- desire to help ameliorate the current global state of healthcare inequality. dent

36 CHINA

Mr. Dou will spend his fellowship year at NCAIDS, China CDC in Beijing, under the mentorship of Han-Zhu Qian, MD, PhD. His research will focus on multi-component HIV intervention packages for Chinese MSM—test, link and care. This study is designed to focus on the strategy and measurement on the reduction of the AIDS mortality

Mr. Dou spent the last year as an AITRP Research Scholar at the Vanderbilt University Institute for Global Health. He believes AITRP has greatly changed his career and uncom- monly improved his research ability. Under his primary mentor’s guidance, Mr. Dou is developing a new grant application for modeling prediction to reduce mortality in HIV/ AIDS patients. One of his ongoing goals is to actively pursue international collaboration. Zhihui DOU, MS LMIC Scholar

Ms. Hazlitt will spend her fellowship year at NCAIDS, China CDC in Beijing, under the mentorship of Zhang Fujie, MD. Her research will focus on examining initiation of ART treatment across China and expand research on ART administration and follow-up.

Ms. Hazlitt's interest in global health began as an undergraduate in International Relations. After pursuing a Master's degree in International Diplomacy, her work as an EMT com- pelled her to apply to medical school, where she also enrolled in Vanderbilt University's Global Health Certificate Program. She hopes to find a full-time career in global health after completing a residency in Emergency Medicine, making a practical impact in pa- tients' lives while effecting change on a global scale. Her academic honors include schol- arships, AOA and Gold's Humanism Society membership. She is the founding Executive Melissa HAZLITT, Director of a free student-run clinic. MA U.S. Scholar ETHIOPIA

Dr. Gebreselassie will spend her fellowship year at Armauer Hansen Research Institute in Addis Ababa, under the mentorship of Susanna Brighenti, PhD. Her research will focus on determining the effects of antimicrobial treatments (vitamin D and phenylbutyrate) in en- hancing innate immune responses in patients infected with Mycobacterium tuberculosis or HIV.

Dr. Gebreselassie has a strong interest in infectious disease research because she was raised in one of Africa’s poorest nations (Ethiopia) where she’s had opportunities to per- sonally witness the debilitating effects of several communicable diseases such as HIV and TB. Dr. Gebreselassie’s passion and calling is global health and the problems she cares about the most are communicable-infectious diseases, illiteracy and health inequality in Nebiat developing countries. Her immediate career goals are to develop systematic methods GEBRESELASSIE, where immune boosting-nutrition based interventions can be used to increase vaccine/drug PhD effectiveness and decrease communication of diseases. LMIC Fellow

37 HAITI

Ms. Harris will spend her fellowship year at Le Groupe Hatien d’Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) in Port-au-Prince, under the mentor- ship of Michael Glickman, MD. Her research will focus on determining the antimycobac- terial activity of a novel small molecule compound against multidrug-resistant and non- replicating Mycobacterium tuberculosis clinical isolates in order to assess the potential efficacy of this compound as a novel drug for the treatment of M. tuberculosis infection.

Ms. Harris received her bachelor’s degree in molecular biology from Princeton Univer- sity. She subsequently joined the Aeras Global Tuberculosis Vaccine Foundation as a Public Health Fellow. Ms. Harris is now an MD-PhD student at the Weill Cornell Medical College Tri-Institutional MD-PhD Program where her graduate research investigates a Kendra HARRIS novel antimycobacterial compound to determine its potential utility in the treatment of U.S. Scholar tuberculosis. Ms. Harris has volunteered with humanitarian organizations in Rwanda, Af- rica, and is interested in global health. She plans to pursue clinical residency in internal medicine with the goal of conducting translational research focused on infectious diseases prevalent in resource-limited areas globally. INDIA

Dr. Foote will spend her fellowship year at Madras Diabetes Research Foundation in My- sore and Chennai, under the mentorship of K.M. Venkat Narayan, MD, MSc, MBA. Her research will focus on investigating the epidemiological links between diabetes mellitus and tuberculosis infection.

Dr. Foote grew up in Tucson, Arizona and was greatly influenced by her experiences growing up in a multicultural border region. She earned her MD/MPH from the University of Arizona before going on to a residency in social internal medicine at Montefiore Medi- cal Center in Bronx, NY. She is currently a fellow in infectious diseases at Emory Univer- sity with research interests in TB/HIV and their relations to social determinants of health and chronic diseases. Dr. Foote has been a traveler from an early age and believes that a Mary FOOTE, career in global health is the perfect combination of her interests. MD, MPH U.S. Fellow

Ms. Ryan will spend her fellowship year at Madras Diabetes Research Foundation in Chennai, under the mentorship of Andrew Hendrick, MD. Her research will focus on a comparison of non-mydriatic and mydriatic screening methods for diabetic eye disease in the Indian population, as well as an examination of the prevalence of macular edema and retinopathy in prediabetic patients.

After growing up in the San Francisco Bay Area, Ms. Ryan attended Carnegie Mellon University in Pennsylvania where she earned a degree in chemical engineering with a mi- nor in biomedical engineering. After graduation she applied to medical school while working at a community health center in Oakland, CA through the AmeriCorps program. The following year she began her studies at Emory University School of Medicine, and Martha RYAN after graduation she plans to pursue a residency in ophthalmology. U.S. Scholar

38 Dr. Shah will spend her fellowship year at Madras Diabetes Research Foundation in Chennai, under the mentorship of Alvin Powers, MD. Despite continued debate over the relative influences of insulin resistance versus impaired insulin secretion, understanding of the underlying physiology of Type 2 Diabetes Mellitus and the metabolic syndrome in Asian-Indian populations is incomplete. Her research will focus on comparing insulin resistance and β-cell insulin secretion in three populations at high risk for the development of Type 2 Diabetes Mellitus and cardiovascular disease: Asian-Indian women with the metabolic syndrome, African-American women and Caucasian American women with the metabolic syndrome, using frequently sampled intravenous glucose tolerance testing.

Dr. Shah, an Ohio native, moved to Philadelphia, PA to earn her MD at Drexel University Sapna SHAH, MD College of Medicine. She then returned to the buckeye state for her residency in Internal U.S. Fellow Medicine at University Hospitals Case Medical Center in Cleveland, Ohio. She is cur- rently completing the second year of her Endocrinology fellowship and the first year of her Master’s of Science in Clinical Medicine at Vanderbilt University Medical Center in Nashville, Tennessee. Her interests are in the unique features of women with the meta- bolic syndrome in Asian Indians compared to Caucasian American women and African American women. KENYA

Dr. Mtui-Temu will spend her fellowship year at Moi University in Eldoret, under the mentorship of Gerald Bloomfield, MD, MPH. Her research will focus on determining HIV positive individuals’ knowledge of and attitude towards cardiovascular risk factors and cardiovascular disease prevention in Kenya.

Dr. Mtui-Temu, a native Tanzanian, received her MD and PhD from Brown University and an undergraduate degree in chemistry from Cornell University. Dr. Mtui-Temu is a co -investigator at Hasbro Children’s Hospital where she is collecting and analyzing epidemi- ological data to create a health care model for pediatric refugee patients by bringing multi- ple specialists together to create easily accessible healthcare. Her research interests and specializations are pathobiology, pediatric endocrinology, and nutrition. Tecla MTUI-TEMU, MD, PhD Fulbright-Fogarty Postdoctoral Scholar PERU

Dr. Burroughs Pena will spend her fellowship year at Universidad Cayetano Heredia in Puno, under the mentorship of Eric Velazquez, MD. Her research will focus on investigat- ing the potential association of chronic exposure to household air pollution with subclini- cal heart failure.

Dr. Burroughs Pena is a cardiology fellow at Duke University. She studied at Emory Uni- versity and Harvard Medical School. Her primary research interest is cardiovascular dis- ease prevention and treatment in Latin America and the Caribbean. Her career influences include Partners in Health and the Cuban health system. Dr. Burroughs Pena has experi- ence working in Cuba, Puerto Rico and the Pan American Health Organization. Her past Melissa awards include the Emory University Robert C. Woodruff Scholarship and the Harvard BURROUGHS PENA, University Presidential Scholar Public Service Initiative Award. Dr. Burroughs Pena’s MD ultimate goal is to hold a position of leadership in a health policy organization. U.S. Fellow 39 RWANDA

Dr. Krebs will spend her fellowship year at University Central Hospital of Kigali (CHUK) in Kigali, under the mentorship of Nathan Thielman, MD. Her research will focus on 1) determining the current state of TBI care in Accident & Emergency at CHUK, 2) evaluat- ing which factors of this clinical care are associated with worsened morbidity and mortal- ity, and 3) utilizing these findings to facilitate local leadership in structured development of a data-driven clinical practice guidelines (CPG) to improve care of TBI patients.

Dr. Krebs is a clinical associate in the Division of Emergency Medicine at Duke Univer- sity. She is interested in designing and implementing sustainable, contextually relevant programs to improve healthcare systems in LMICs. Local direction and a focus on the Elizabeth KREBS, MD priorities of the people she serves guides her current and future projects planned to prevent U.S. Fellow injuries and improve patient centered outcomes. Her past experience has built a strong foundation in leadership, collaboration, and project development. Immediately prior to her time at Duke University she served as CEO of a 501(c)3 nonprofit organization, leading an effort to educated and study the impact of ultrasound use by physicians in Rwanda. SOUTH AFRICA

Dr. Franz will spend her fellowship year at University of KwaZulu-Natal in Durban, under the mentorship of Helen Egger, MD. Her research, titled The KwaZulu-Natal Autism study, will focus on the largely Zulu but multi-cultural community in the province of KwaZulu-Natal, South Africa. The primary purpose of the KwaZulu-Natal Autism study is to explore how best to identify Zulu children who have an autism spectrum disorder. The long term goal of this study is to lay the groundwork for a cross-cultural multi- country study on the epidemiology of autism spectrum disorders where questions around incidence, prevalence, and causation can be addressed.

Dr. Franz’s research interests are in global early childhood cognitive and social-emotional development. She received her medical degree from Stellenbosch University in South Africa, completed a year of internship in Namibia, and a year of community service in Lauren FRANZ, rural South Africa. She has an MPH from Emory, and is currently at Duke where she is MBChB, MPH enrolled in a training program that includes general psychiatry, child psychiatry, develop- U.S. Fellow mental epidemiology, and global health. In 2012, Dr. Franz was selected as a Zero to Three Leaders of the 21st Century Fellow.

Ms. Waxman will spend her fellowship year at the Centre for the AIDS Programme of Research in South Africa (CAPRISA) in Durban, under the mentorship of Quarraisha Ab- dool Karim, PhD. Her research will focus on assessing safety and effectiveness of Teno- fovir provision through family planning services in South Africa, to incorporate qualita- tive methods for understanding its utility in practice and inform how to effectively imple- ment the product across many clinics.

Ms. Waxman has addressed HIV-related health disparities through advocacy, program- matic development and public health research in Africa and at the U.S. NIH. Her MPH thesis (London School) focused on young women’s vulnerability to HIV infection, in- Aliza WAXMAN, MSc spired by her work launching Female-Empowerment-Through-Football in Kenya. Her Fulbright-Fogarty Stu- goal is to combine evidence-based science with real-life narratives of women to inform dent the implementation of Microbicides. An accomplished photographer, Aliza has created photo-documentaries, including: “Faces-of-Hope,” documenting the many faces of HIV/ AIDS; “There's-a-World-Cup-in-My-Village,” documenting her work in Kenya; and “Santé-Publique-Ayiti,” documenting public health in Haiti. Ms. Waxman plans to dedi- cate her career to improving women’s health globally. 40 TANZANIA

Dr. Stanifer will spend his fellowship year at Kilimanjaro Christian Medical Centre in Moshi, under the mentorship of Uptal Patel, MD. His research will focus on a cross- sectional survey of the general population for chronic kidney disease screening. He will also be screening for some of its common risk factors, such as diabetes, obesity, and hy- pertension.

Dr Stanifer's research interests include understanding the burden of chronic diseases— specifically chronic kidney disease—in sub-Saharan Africa. By participating in the NIH Fogarty Global Health Program, he anticipates gaining the additional research and scien- tific skills to conduct meaningful and productive investigations in a global health setting. His plans are to initially examine the epidemiology of chronic kidney disease in Tanzania, John STANIFER, with the future design of building up to and implementing a prevention strategy across a MD, MSc much broader region. His career goals are to continue work in global health nephrology as U.S. Fellow an academic physician. VIETNAM

Mr. Sobowale will spend his fellowship year at Danang Psychiatric Hospital in Danang, under the mentorship of Bahr Weiss, PhD. His research will focus on investigating an integrative task-shifting model of depression treatment with primary care physicians, nurses, and community health workers in Vietnam, and assessing the effectiveness of this collaborative care model on depressive symptoms and quality of life as well as barriers to care.

Mr. Sobowale is a Doctor of Medicine candidate interested in innovative methods to alle- viate the burden of disease of mental illnesses in resource-limited settings worldwide. He has explored access to mental health care in Japan and Hong Kong. Currently, he is ex- ploring unique risk factors for depression and suicide ideation in Chinese medical students and creation of a wellness curriculum. In addition, he has worked on various global health Oluwafikunmi efforts at his medical school and is submitting a paper on predictors of medical students SOBOWALE working in global health settings. He plans to continue working in global mental health U.S. Scholar moving forward.

ZAMBIA

Dr. Howard will spend her fellowship year at the Centre for Infectious Disease Research in Zambia (CIDRZ) in Lusaka, under the mentorship of Benjamin Chi, MD, MSc and Kathryn Edwards, MD. Her research will focus on the epidemiology of pediatric diarrheal infections before and after rotavirus vaccine implementation in Lusaka Province.

Following pediatrics residency, Dr. Howard worked as a Pediatric AIDS Corps physician in Botswana for one year prior to beginning fellowship in pediatric infectious diseases at Vanderbilt University. During her fellowship, she also completed coursework for her Master of Public Health degree to combine her clinical background with training in epide- miologic, clinical, and translational research. Her fellowship research has focused on the application of genomic and proteomic analyses to vaccine evaluation. Her primary re- Leigh HOWARD, search interest is the application of these analyses and an understanding of the epidemiol- MD, MPH ogy of vaccine-preventable infections in resource-limited settings to enhance vaccine ac- U.S. Fellow cess and delivery globally.

41 Dr. Kvalsund will spend her fellowship year at the University of Zambia in Lusaka and Mazabuka, under the mentorship of Douglas Heimburger, MD, MS. Her research will focus on investigating the utility of screening instruments for identifying distal symmetric polyneuropathies (DSPN) in Zambian HIV patients. In addition, this study will investigate the characteristics of DSPN in this population and impact of co-morbid nutritional and toxic etiologies on neuropathy progression and severity.

Dr. Kvalsund has been committed to a career in global health since her initial introduction to the field as a student of epidemiology and medicine at Michigan State University. Her prior experiences have included serving as a Fulbrighter to Zambia in 2003-2004 and Fo- Michelle KVALSUND, garty International Clinical Research Scholar in Fortaleza, Brazil in 2007-2008. In her DO, MS final year of residency training at Vanderbilt University, Dr. Kvalsund received a Fogarty U.S. Fellow Global Health Fellowship and American Brain Foundation Practice Research Training Grant to study HIV-associated peripheral neuropathies. Her research interests include the neurological sequelae of infectious disease and health implementation research.

42 43 44 GHES

Dr. Anand spent her fellowship year at Center for Chronic Disease Control in New Delhi, India, under the mentorship of Glenn Chertow, MD, MPH. Her research focused on a sur- veillance study (called CARRS) that is establishing prevalence and risk factors of cardi- ometabolic diseases in New Delhi, Chennai, and Karachi. She also planned a substudy within a randomized control trial.

Dr. Anand is a nephrologist interested in studying kidney disease in a global health con- text. She completed her MD from Washington University School of Medicine, residency in internal medicine from Brigham and Women's Hospital, and nephrology training from Stanford University. She has pursued global health from the start of her career, undertak- Shuchi ANAND, MD ing a Fogarty internship in Mali and CDC fellowship in Thailand. Dr. Anand hopes to Clinical Instructor build on her work as a Fogarty GHES fellow to establish prevalence and incidence of Stanford University chronic kidney disease in South Asia and to evaluate low-cost management strategies for patients with diabetic kidney disease.

Ms. Berman spent her fellowship year at Fundação Oswaldo Cruz (FIOCRUZ) in Salva- dor, Brazil, under the mentorship of Lee Riley, MD. Her research focused on investigating the spread of drug resistance in E. coli.

Hillary is a fourth year PhD student in the Infectious Disease and Immunity program at UC Berkeley. She received her MPH in Epidemiology/Biostatistics from UC Berkeley in 2010. She will graduate in the spring of 2014. Hillary is interested in drug development, molecular epidemiology, and antimicrobial resistance.

Hillary BERMAN, MPH PhD Candidate University of California, Berkeley

45 Dr. Bojko spent her fellowship year at the Ukrainian Institute for Public Health Policy (UIPHP) in Kyiv, Ukraine, under the mentorship of Frederick L. Altice, MD, MA. Her research focused on using qualitative methods (participation observation, key informant and in-depth interviews, focus groups) to identify and assess the barriers and facilitators to receiving medication-assisted therapies (MAT) including methadone (MMT) and bupre- norphine treatment (BMT) for HIV prevention and treatment in Ukraine. Data will be used to examine the health beliefs and attitudes about MAT by individuals at the client-, pro- gram- and community-levels and to gain an understanding of the complex array of under- lying causes for the current phenomenon of poor treatment entry and retention in MAT in Ukraine. Macro-level structural factors (economic, political, social, cultural) associated with HIV/STI and substance abuse in Ukraine will also be assessed. Martha BOJKO, PhD Postdoctoral Research Dr. Bojko earned her PhD in Anthropology from the University of Connecticut and is cur- Associate rently a Postdoctoral Research Associate at Yale University School of Medicine. As an Yale University applied medical anthropologist with a public health focus, Dr. Bojko’s areas of scientific interest include using mixed methods research to study HIV/STI prevention and treatment, gender, sexual health, and substance abuse among adults in global settings, specifically in Ukraine, where the HIV epidemic is fueled by injection drug use. She has received several awards to conduct her research in Ukraine, including a Fogarty Global Health Equity Scholar fellowship and a Fulbright award.

Dr. Chibanda spent his fellowship year at the University of Zimbabwe in Harare, Zim- babwe, under the mentorship of Cheryl Gore-Felton, PhD. His research, titled The Friend- ship Bench, was a cluster randomised controlled trial of a brief psychological intervention for common mental disorders delivered by lay health workers.

Dr. Chibanda earned his MD in the Czech republic. He then moved to Zimbabwe where he studied psychiatry and obtained a Master’s in medicine with a major in psychiatry, and later an MPH. He worked as a WHO consultant in several African countries in the fields of mental health legislation and human rights. His research interests are task shifting in mental health and the use of alternative interventions for ADHD and substance abuse such as neuro-feedback and balance auditory visual integration exercises (BALAVISX). He Dixon CHIBANDA, lives in Zimbabwe and is a visiting researcher at the Institute of Psychiatry in London. MD, MMed, MPH Psychiatrist University of Zimbabwe

Dr. Islam spent his fellowship year at International Centre for Diarrhoeal Disease Re- search, Bangladesh (ICDDR,B) in Dhaka, Bangladesh, under the mentorship of Dr. Alex- andria Boehm, PhD. His research focused on determining the prevalence and spread of NDM-1-producing organisms in the Dhaka city environment along with characteristics of organisms.

After receiving his PhD from Wageningen University in the Netherlands in 2009, Dr. Is- lam joined ICDDR,B and was assigned to develop the capacity of conducting research related to food microbiology. Ensuring safe food is a huge challenge for Bangladesh and there were hardly any capacity in the country even to analyse food samples for common foodborne pathogens. With the support from the Institute itself and from a few other do- Mohammad Aminul nors, Dr. Islam set up the food microbiology laboratory which is now considered as the ISLAM, PhD, MSc only laboratory in the country doing research in the area of food safety. Associate Scientist ICDDR,B

46 Dr. Kazibwe spent her fellowship year at Makerere University in Kampala, Uganda, under the mentorship of Enock Matovu, PhD. Her research focused on tsetsefly metabolomics/ transcriptomics and establishment of trypanosome infection in wild vector populations of Northern Uganda.

Dr. Kazibwe earned her PhD from the University of Glasgow in Molecular Parasitology of drug resistance in HAT in Uganda. She earlier researched on antimalarial drug resistance contributing to an MSc degree from the same university. She has focused on genetic char- acterisation of trypanosomes from the T. b. rhodesiense- T. b. gambiense interface region of Northern Uganda supported by European Foundations Initiative for African Research into Neglected Tropical Diseases (EFINTD). Dr. Kazibwe is presently focusing on wild Anne Nalunkuma tsetsefly vector metabolomics/transcriptomics supported by the GHES program which is KAZIBWE, PhD, MSc an opportunity for her to be mentored as a strong researcher capable of contributing to- Postdoctoral Fellow wards controlling and influencing policy change of HAT. Makerere University

Dr. Nduba spent his fellowship year at Kenya Medical Research Institute (KEMRI) in Kisumu, Kenya, under the mentorship of Kevin Cain, MD. His research focused on deter- mining the incidence of tuberculosis (TB) in adolescents and infants in preparation for TB vaccine trials. In addition, additional laboratory testing was done using GeneXpert on stored sputum samples.

Dr. Nduba completed his medical degree at the University of Nairobi and subsequently took a career in public health that included HIV and tuberculosis (TB). After obtaining a public health degree from the University of Washington funded through a Fogarty fellow- ship, he received an award from the European and Developing Countries Clinical Trials Videlis NDUBA, Partnership (EDCTP) to develop a TB vaccine trial site in Western Kenya. Addressing the MBChB, MPH twin epidemics of TB and HIV that are a high cause of morbidity and mortality remain his PhD Candidate primary focus. Dr. Nduba aspires to develop excellence in epidemiology and provide men- University of torship to Kenyan scientists. He hopes to see TB globally eliminated. Amsterdam

Dr. Openshaw spent his fellowship year at the International Center for Diarrheal Diseases Research, Bangladesh in Dhaka, Bangladesh, under the mentorship of Steve Luby, MD. His research focused on developing a system to discover new zoonotic diseases spilling over from animals to people throughout Bangladesh.

Dr. Openshaw is a fellow in Infectious Diseases at Stanford University Hospital. After completing his undergraduate studies at Stanford University, he was trained in Ecology at Oxford University and received his medical degree from the University of Pennsylvania. He completed his training in internal medicine at Stanford University Hospital. Dr. Open- shaw is interested in the ecology of infectious diseases, disease surveillance, and the use of new technologies in the detection, tracking, and treatment of infectious diseases. John OPENSHAW, MD, MSc Infectious Diseases Fellow Stanford University Hospital

47 GloCal

Dr. Chuquiyauri spent his fellowship year at Universidad Peruana Cayetano Heredia (UPCH) UCSD Satellite Research Laboratory in Iquitos City, Peru, under the mentorship of Joseph M. Vinetz, MD; Alejandro Llanos Cuentas, MD, PhD and Kimberly Brouwer, PhD. His research focused on malaria transmission in rural faraway villages of the Peru- vian Amazon, identifying the rol of asymptomatic malaria and migration on maintenance of transmission.

Dr. Chuquiyauri earned his MD from UPCH, and currently is a PhD candidate in the Global Health program at University of California San Diego / San Diego State Univer- sity. He has been doing malaria/tuberculosis/leptospirosis research in the Peruvian Ama- Raul zon since 2004 and his career goals are to lead and contribute to the understanding of the CHUQUIYAURI, MD malaria disease transmission with the ultimate goal of its elimination. PhD Candidate University of California San Diego / San Diego State University

Dr. Fenner spent her fellowship year at the Smithsonian Tropical Research Institute in Panama City, Panama, under the mentorship of William Gerwick, PhD; Elizabeth Winze- ler, PhD and Phyllis Coley, PhD. Her research focused on natural product drug discovery, collecting marine cyanobacteria in Panama and identifing metabolites from the cyanobac- teria that could be used to treat malaria, leishmaniasis, Chagas' disease.

As an undergraduate, Dr. Fenner sought to combine her love of chemistry, biology, and Spanish. She pursued a graduate degree in medicinal chemistry. For her doctorate, she synthesized a series of anti-infective carbohydrates that she used to demonstrate selective binding to pathogen surface proteins. While a graduate student, she did an internship in natural products chemistry in Panama. Now a postdoctoral researcher, she has returned to Amanda FENNER, Panama to lead the lab where she was once a visiting student. She is combining her me- PhD dicinal chemistry background with natural products chemistry to discover, develop, and Postdoctoral Researcher design new treatments for neglected diseases. Scripps Institution of Oceanography

Ms. Harding spent her fellowship year at International Centre for Diarrhoeal Disease Re- search, Bangladesh (ICDDR,B) in Parbatipur, Bangladesh, under the mentorship of Chris- tine Stewart, PhD, MPH; Tahmeed Ahmed, MBBS, PhD and Lia Fernald, PhD, MBA. Her research focused on evaluating the adherence of rural Bangladeshi women to lipid- based nutrient supplements and iron and folic acid tablets. A mix methods approach was used to define adherence and assess barriers and facilitators to supplement adherence.

Ms. Harding is a doctoral candidate of the Graduate Group in Nutritional Biology at the University of California, Davis. She is also pursuing a designated emphasis in the Pro- gram in International and Community Nutrition. The unique challenges associated with devising effective, sustainable, and culturally acceptable interventions to improve nutri- Kassandra HARDING tion among diverse populations have led her to pursue a career in global health. Upon PhD Candidate completing her doctoral training, she aims to collaborate with international organizations University of to conduct novel clinical and translational research to address nutritional problems in dis- California, Davis advantaged populations.

48 Dr. Mridha spent his fellowship year at International Centre for Diarrhoeal Disease Re- search, Bangladesh (ICDDR,B) in Dhaka, Bangladesh, under the mentorship of Kathryn G. Dewey, PhD; Laura Reichenbach, MPA, ScD and Abdullah Baqui, MBBS, DrPH. His research, named Rang-Din Nutrition Study (RDNS), focused on the prevention of malnu- trition among women and children in Bangladesh through home-fortification approaches using lipid-based nutrition supplements (LNS) and micronutrient powder (MNP).

Dr. Mridha is a PhD candidate in the department of Nutrition at the University of Califor- nia, Davis. He is also working as the head of the Maternal and Reproductive Nutrition Research Group at ICDDR,B. After his graduation as a medical doctor, he earned his MSc Malay MRIDHA, in Health Economics, MSc in Nutrition, and Master’s in Public Health. He worked for MBBS, MSc, MPH BRAC, Bangladesh Women’s Health Coalition (BWHC), Diabetic Association of Bangla- PhD Candidate desh, HIV/AIDS and STD Alliance-Bangladesh, and Concern Bangladesh. His research University of interests include maternal and child health, chronic diseases, and scaling up of evidence- California, Davis based nutrition. He was an author of Lancet Maternal Survival Series.

Dr. Nakanjako spent her fellowship year at the Infectious Diseases Institute (IDI), Maker- ere University College of Health Sciences in Kampala, Uganda, under the mentorship of Warner Greene, MD, PhD; Yukari Manabe, MD and Harriet Mayanja-Kizza, MBChB, MMed, MS. Her research focused on the role of regulatory T-cells in suboptimal CD4 recovery among HAAT-treated adults in Uganda.

Dr. Nakanjako is an internist, trained at Makerere University and University of Antwerp. She is a postdoctoral research fellow in Infection and Immunity at IDI. She has particular interest in infectious diseases including HIV/AIDS, malaria and TB. She has over 10 years experience in adult HIV/AIDS care and implementation research, and is currently focus- ing on translational immunology research to improve immune recovery among HAART- Damalie treated adults. Dr. Nakanjako received the prestigious Merle A. Sande Health Leadership NAKANJAKO, award in recognition of the contribution her work has made towards improving the lives PhD, MBChB, MMed of people living with HIV in Africa. Postdoctoral Fellow Makerere University

Dr. Onono spent her fellowship year at Kenya Medical Research Institute (KEMRI) in Migori, Kenya, under the mentorship of Craig Cohen, MD, MPH; Elizabeth Bukusi, MBChB, MMed, MPH, PhD, PGD and Glenda Gray, MBBCH, FCPaeds. Her research focused on determining the role of HIV/AIDS related stigma and structural factors at the individual, community and health facilities level on PMTCT failure

Dr. Onono is a medical doctor and research scientist. She has played a key role in translat- ing many research findings into routine clinical practice through innovative approaches to HIV, TB, FP, and PMTCT program implementation. She has been instrumental in the development, implementation and evaluation of various systems, including the district Maricianah ONONO, level mentorship and supervision programs, laboratory networking and sample transport MBChB, MSc systems, task shifting, defaulter identification and follow up systems, and linkages and Medical Doctor referral networks—all aimed at improving maternal and child health outcomes. She is a Kenya Medical member of several national TWGs on sexual reproductive and child health. Research Institute

49 Dr. Wolf spent her fellowship year at Kenya Medical Research Institute (KEMRI) in Ki- sumu, Kenya, under the mentorship of Craig Cohen, MD, MPH; Collette Auerswald, MD, MS and Bonnie Halpern-Felsher, PhD. Her research focused on determining the reasons adolescents become lost to follow-up (LTFU) from HIV clinic in Kisumu, Kenya. They conducted (1) focus groups with community health workers, (2) semi-structured inter- views with HIV+ adolescents who are LTFU, and (3) semi-structured interviews with school educators.

Dr. Wolf’s career goals include obtaining a faculty position in adolescent medicine and pursuing a career in clinical medicine and global health research. She will apply for NIH and other foundation funding to support her research endeavors. Dr. Wolf has been in- Hilary WOLF, MD credibly influenced by her previous international experiences and her team of multidisci- Adolescent Medicine plinary mentors in the U.S. and in Kenya. At the end of this academic year, she will have Clinical Fellow completed a fellowship in Adolescent Medicine and Reproductive Infectious Diseases University of from UCSF and will be starting as an Assistant Professor at Georgetown University that California, will consist of time devoted to research. San Francisco UJMT

Dr. Ballard spent her fellowship year at Universidad Peruana Cayetano Heredia (UPCH) in Lima, Peru, under the mentorship of Robert Gilman, MD, DTM&H. Her research fo- cused on evaluating the contribution of norovirus to diarrhea in children under five years of age following rotavirus vaccine implementation.

Dr. Ballard is dually enrolled in the Johns Hopkins International Health (Global Disease Epidemiology and Control) PhD and Preventive Medicine Residency programs. Prior to Hopkins, she served as a Naval Flight Surgeon, engaged in research and patient care throughout the world. After Fogarty, she will return to the Navy to serve as the local Dep- uty Director for the DoD's Global Emerging Infections Surveillance System in Lima, Sarah-Blythe Peru. BALLARD, MD, MPH International Health Resident Johns Hopkins University

Dr. McCollum spent his fellowship year at Project UNC in Lilongwe, Malawi, under the mentorship of Charles van der Horst, MD. His research focused on point-of-care infant HIV testing in hospitalized Malawian infants.

Dr. McCollum spent five years living and working in Malawi immediately after pediatric residency. This included his Fogarty clinical research fellowship. His initial clinical re- search interests focused on pediatric HIV but, through his experiences, have broadened to childhood respiratory illnesses, including HIV-related respiratory disease. As a result, he returned to the U.S. to train as a postdoctoral fellow at Johns Hopkins School of Medicine in pediatric pulmonology. Dr. McCollum continues to do pediatric respiratory research in Africa and plans on applying for the IRSDA. Eric MCCOLLUM, MD Pediatric Pulmonology Fellow Johns Hopkins University School of Medicine

50 Mr. Pac spent his fellowship year at the Infectious Diseases Institute (IDI) in Kampala, Uganda, under the mentorship of Yukari Manabe, MD. His research focused on screening for tuberculosis, cryptococcus, and cardiovascular disease in an HIV-positive cohort of rural Ugandans initiating ART.

Mr. Pac graduated summa cum laude and Phi Beta Kappa from Bowdoin College where he majored in biochemistry and German. He will graduate AOA next year from the MD program at the University of Colorado School of Medicine. He is interested in pursuing an academic career as a physician scientist and hopes to contribute to the fields of infectious disease and immunopathology. Lincoln PAC Fulbright-Fogarty Alumus MD Candidate University of Colorado

Dr. Tang spent her fellowship year at UNC Project-Malawi in Lilongwe, Malawi, under the mentorship of Mina Hosseinipour, MD, MPH. Her research focused on evaluating the short-term and long-term impact of an emergency obstetrics and neonatal care (EmONC) mentoring program on EmONC knowledge and skills.

Dr. Tang earned her MD from Baylor College of Medicine and did her residency training in Obstetrics & Gynecology at Brigham & Women's Hospital/Massachusetts General Hos- pital. She then completed a 2-year Family Planning Fellowship and MS in Clinical Re- search at UNC. Her career goal is to become a leading academic researcher in global women's health and family planning, which has been influenced by her previous interna- tional health experiences in China, Central America, and Malawi. She joined UNC as an Jennifer TANG, Assistant Professor in her department's Division of Global Women's Health and moved MD, MSCR full-time to Lilongwe, Malawi in August 2012. Assistant Professor University of North Carolina NPGH

Ms. Chomchey spent her fellowship year at Chulalongkorn University in Bangkok, Thai- land, under the mentorship of Cecilia Shikuma, MD. Her research focused on factors af- fecting the intention to take non-occupational HIV post-exposure prophylaxis among Thai men who have sex with men. The study is mixed method, combining qualitative and quan- titative design.

Ms. Chomchey received her Bachelor’s degree from the Thai Red Cross College of Nurs- ing in 2000, and won a place to undertake her Master’s degree at Mahidol University. She has been interested in medical research since her undergraduate studies and has worked in the HIV field for the past nine years. In 2011, Ms. Chomchey enrolled in the PhD pro- gram. Her career goal is to translate knowledge from HIV clinical trials into improved Nittiya CHOMCHEY, health systems for resource-constrained settings. Her research interests include HIV/AIDS MSc and MSM; especially factors affecting nPEP use, nPEP effectiveness and safety in the PhD Candidate Thai MSM population. Chulalongkorn University

51 Dr. Cornejo spent his fellowship year at Instituto Nacional de Ciencias Neurologicas (INCN) in Lima, Peru, under the mentorship of Pilar Mazzetti, MD, MS. His research, titled “Target Sequencing Analysis of Parkinson's Disease Genes in a Native Amerindian Population from Puno-Peru," focused on generating a list of sequence variants and corre- sponding frequencies for 12 PD-related genes in 50 healthy Quechua Amerindian con- trols.

Dr. Cornejo received his MD from San Agustin University. In 2010, during the last year of his Neurology residency at INCN through San Marcos University, Dr. Cornejo was selected for the FICRS-F fellowship, working on neurogenetics. During his fellowship Mario CORNEJO, MD through the NPGH Consortium, he developed research projects on inherited neurological Doctor diseases, genetics of Parkinson’s disease on "mestizo" and native Amerindian popula- Instituto Nacional de tions, and a national survey to characterize human genetic services, with the support of a Ciencias Neurologicas mentoring team from both INCN and the University of Washington.

Dr. Martin spent her fellowship year at Komfo Anokye Teaching Hospital in Kumasi, Ghana and at Mulago Hospital in Kampala, Uganda. Her research focused on capacity building in cancer surveillance in sub-Saharan Africa. She gained multi-national exposure to African cancer registries and assisted in registry development in Kumasi, Ghana.

Dr. Martin strives to be an interdisciplinary scientist with a service orientation to her work. She completed her BA at the University of Pennsylvania as a University Scholar and Ronald E. McNair Scholar. Subsequently earning an MPH from the University of Ghana during a Rotary Ambassadorial Scholarship and a MSc in epidemiologic sciences from the University of Michigan. In 2012, she was awarded her PhD in epidemiology from the University of Illinois at Chicago. Dr. Martin’s work focuses on eliminating Iman K. MARTIN, health disparities by examining interactions between genetics, behavior, and social- PhD, MPH, MSc structural determinants of health. Global Health Fellow University of Washington/ Komfo Anokye Teaching Hospital

Mr. Onchiri spent his fellowship year at Kenya Medical Research Institute (KEMRI) in Nairobi, Kenya, under the mentorship of Judd Walson, MD, MPH. His research focused on frequency, risk factors and outcomes of Bacteremia among febrile children in rural Western Kenya.

Mr. Onchiri was born in rural Western Kenya, about 400 miles away from the capital city of Nairobi. He graduated with a Bachelor of Science degree from University of Nairobi in 2002. He has won scholarships twice to study for a Master of Science in biostatistics (2005-2007), and a PhD in epidemiology (2010-current) both at the University of Wash- ington. He hopes to graduate with a PhD in late 2013 or early 2014. In 2008-2009, Mr. Onchiri was a Fogarty International Clinical Research Scholar based at the University of Frankline ONCHIRI, Nairobi, Kenya. MSc PhD Candidate University of Washington / Kenya Medical Research Institute (KEMRI)

52 VECD

Dr. Chidumayo spent her fellowship year at University Teaching Hospital in Lusaka, Zambia, under the mentorship of Douglas Heimburger, MD, MS. Her research focused on looking into the cardiovascular and GIT mechanisms of early mortality in adults with se- vere malnutrition within 12 weeks of initiating antiretroviral therapy (MEMART study).

Dr. Chidumayo is a registrar in Internal Medicine with interests in Neurology, focusing her thesis on peripheral neuropathies in HIV/AIDS and the effects nutrition on disease progression. She has been inspired to work hard and take an interest in research by her parents who are both scholars and published researchers. Working with the Global Health team and the Fogarty alumni has taught her the skills required to carry out medical re- search to improve the quality of care for patients in Zambia. Dr. Chidumayo trained in Takondwa neurophysiologic procedures and MDR-TB/HIV Co-Management. CHIDUMAYO, MBChB Internal Medicine Registrar University of Zambia School

Dr. Kalokhe spent her fellowship year at the National AIDS Research Institute in Pune, India, under the mentorship of Seema Sahay, PhD and Carlos del Rio, MD. Her research focused on developing a culturally-tailored scale to measure domestic violence among married women in Pune, India.

Dr. Kalokhe's long-term career goals include developing effective and sustainable inter- ventions to reduce gender-based violence and HIV/STI risk among women in India and evaluating the effects of violence on physical and mental health.

Ameeta KALOKHE, MD, MSc Senior Associate, Infectious Diseases Emory University School of Medicine

Dr. Love spent his fellowship year at Soddo Christian Hospital in Wolaita Soddo, Ethio- pia, under the mentorship of Jonathan D. Pollock, MD. His research focused on establish- ment of formal institutional breast cancer registries at four hospitals in urban and rural Ethiopia with retrospective registration of patients and training of cancer registrars for ongoing enrollment.

Dr. Love earned his MD at the University of Miami, is an MPH candidate at Emory’s Rollins School of Public Health, and is currently in clinical training in General Surgery at Emory University. He has extensive research experience including a surgical research fellowship at Harvard Medical School and his international experiences in low-resource Timothy LOVE, MD settings have led him to pursue a career in global health. His Fogarty fellowship has fo- Surgical Resident and cused on cancer epidemiology in Ethiopia. After the completion of his surgical residency, MPH Candidate he plans to return to Ethiopia to practice surgery and continue his engagement in cancer Emory University research and control.

53 Ms. Shaikh spent her fellowship year at Public Health Foundation of India in New Delhi, India, under the mentorship of K.M. Venkat Narayan, MD, MSc, MBA. Her research fo- cused on exploring the relationships between globalization and unhealthy weight among adolescents that exist in a developing country. She was developing a tool to measure mul- tiple components of the changing environment experienced by young people and their families.

Ms. Shaikh is a registered dietitian and graduate of Georgia State University (GSU); Uni- versity of Pune; and S.N.D.T. Womens’ University, Mumbai, where she completed her Master’s degrees in nutrition and dietetics and her undergraduate degree in foods and nu- trition. She won the Outstanding Graduate Student Award at GSU, the student research Nida SHAIKH, competition at the Georgia Nutrition Council conference, and was also a finalist in the MS, MSc Nutrition Graduate Student Research Award competition at Experimental Biology 2011. PhD Candidate Ms. Shaikh’s overall professional goal is dedicated towards establishing a career in child Emory University

54 GHF & FULBRIGHT‐FOGARTY YEAR 2 TRAINEES

PAGE

COUNTRY

GHF SITE Peru 31

DESIGNATION

GHF Fulbright-Fogarty Post- doctoral Scholar

CONSORTIUM

DEGREE(S)

MBT MBT NPGH Fellow U.S. Cameroon 26 c NPGH LMIC Scholar Kenya 27 27 Kenya Scholar LMIC c NPGH UJMT U.S. Scholar China 19 19 China Scholar U.S. UJMT ADVANCED

NAME

don SM SM don Fellow GHES U.S. Ethiopia 7 FIRST

NAME

LAST Burroughs Pena Pena Burroughs Melissa 40 Jagger MD Rwanda Fellow 26 Ghana Stanifer Fellow MD Pam Hansoti MD U.S. John VECD Elizabeth Krebs 31 U.S. MSc PhD, Thailand Fellow VECD NPGH Bhakti MD MD, MSc Rockefeller Oteng MPH MBChB, Sumidtra Fellow U.S. Prathep LMIC NPGH UJMT Radhakrishna VECD UJMT Kedar Peru Rose Fellow U.S. U.S. Fellow Fellow U.S. MPhil MBBS, PhD, GloCal Malawi 39 John Tanzania Africa South Fellow LMIC MPH MD, 22 20 41 India GloCal 12 Fellow U.S. Mozambique 14

INTEREST

RESEARCH Cancer Kohler Kelly MSPH UMJT U.S. Scholar Malawi 20 20 Malawi Scholar U.S. UMJT MSPH NPGH MD Kelly Anya Cancer Cancer Kohler Cancer Romanoff Ddungu Henry MMed MBChB, NPGH Fellow LMIC Uganda 32 Cancer Sivasubramaniam Priya Priya Cancer Sivasubramaniam PhD, Anna Babakhanyan HIV/Malaria/TB Cardio & Blood) Lung (Heart, Cardio & Blood) Lung (Heart, Cardio & Blood) Lung (Heart, Medicine/ Emergency Surgery Medicine/ Emergency Surgery Medicine/ Emergency Surgery Medicine/ Emergency Surgery Medicine/ Emergency Surgery Medicine/ Emergency Surgery Health Systems Research Shen MS HIV/Malaria/TB Cyrus Ayieko HIV/Malaria/TB Gor Ashimolowo Tolu UJMT Scholar U.S. Ghana 19 55

PAGE

COUNTRY

GHF SITE

DESIGNATION

GHF

CONSORTIUM

DEGREE(S)

MHS GloCal U.S. Fellow Peru 14 14 Peru Fellow U.S. GloCal MHS MPH VECD U.S. Fellow India 38 38 India Fellow U.S. VECD MPH il NPGH LMIC Scholar Cameroon 26 26 Cameroon Scholar LMIC il NPGH H NPGH U.S. Scholar Kenya 27 27 Kenya Scholar U.S. H NPGH 20 Malawi Scholar U.S. , MS H UMJT VECD Fellow U.S. Zambia 42 BChB, MPH BChB, MPH NPGH Fellow LMIC Kenya 28 PhD VECD LMIC Fellow Ethiopia 37 37 Ethiopia Fellow LMIC VECD PhD ADVANCED

NAME

FIRST

NAME

LAST

INTEREST

RESEARCH HIV/Malaria/TB Achonduh Olivia MPh Olivia Achonduh HIV/Malaria/TB China 37 HIV/Malaria/TB Scholar HIV/Malaria/TB MS MD, 19 Bahr Ghana Fellow Dou HIV/Malaria/TB LMIC Zhihui ? VECD Cyrus Driss HIV/Malaria/TB Adel U.S. Nebi Nate HIV/Malaria/TB Foote Mary UMJT Elena MP HIV/Malaria/TB Gebreselassie CTROPMED MA, MD, NPGH China 37 Scholar MPH PhD, Karen Hamre HIV/Malaria/TB Fellow MA U.S. HIV/Malaria/TB U.S. Melissa HIV/Malaria/TB Hazlitt GHES VECD M Uganda Harris HIV/Malaria/TB Fellow U.S. Elizabeth HIV/Malaria/TB Irungu 32 Kendra PhD, Hu HIV/Malaria/TB Peru Kelika Konda HIV/Malaria/TB DO Kelley HIV/Malaria/TB MP Fengyu Michelle 8 Kvalsund HIV/Malaria/TB PhD MD, Kathryn James Kozycki Lancaster HIV/Malaria/TB VECD MPH PhD, Christina UJMT U.S. Scholar MPH MD, NPGH Fellow LMIC Haiti UJMT Fellow U.S. China Fellow U.S. 38 Thailand 18 Rwanda 31 22 56

PAGE

COUNTRY

GHF SITE Brazil 36 South Africa Africa South 40

DESIGNATION

GHF Fulbright-Fogarty Student Fulbright-Fogarty Student

CONSORTIUM UJMT U.S. Fellow South Africa 22 22 Africa Fellow South U.S. UJMT

DEGREE(S)

MMed, MAS MAS MMed, GloCal Fellow LMIC Uganda 15 MSW GloCal U.S. Fellow Mexico 14 14 Mexico Fellow U.S. GloCal MSW MPH GloCal LMIC Fellow Peru 15 15 Peru Fellow LMIC GloCal MPH D, MPH D, MPH GloCal Fellow U.S. Kenya 13 SPH NPGH U.S. Scholar Peru 30 30 Peru Scholar U.S. SPH NPGH ADVANCED

NAME

isten MPH isten MPH Scholar NPGH Peru U.S. 29 FIRST

NAME

LAST

INTEREST

RESEARCH HIV/Malaria/TB Lee Lana MD UJMT U.S. Fellow Uganda 23 23 Uganda Fellow MD Lee HIV/Malaria/TB Lana U.S. 21 MD, Malawi HIV/Malaria/TB UJMT Fellow Luis M HIV/Malaria/TB Menacho MBChB Tatiana Li U.S. HIV/Malaria/TB Metcalf 13 Mexico UMJT Scholar Dennis PhD Ongubo HIV/Malaria/TB 8 Ukraine Fellow MPH Paich HIV/Malaria/TB Heather Duo U.S. PhD VECD Miguel GloCal Pinedo HIV/Malaria/TB U.S. Maxim GHES Polonsky HIV/Malaria/TB Kristopher Schwebler HIV/Malaria/TB UJMT Scholar U.S. Ghana 19 HIV/Malaria/TB Semeere Aggrey S. MBChB, S. Ph Aggrey PhD, HIV/Malaria/TB Semeere Jennifer Syvertsen HIV/Malaria/TB HIV/Malaria/TB MSc Lianne Urada HIV/Malaria/TB Aliza Ton HIV/Malaria/TB Waxman VECD Quy MPH MD, NPGH Fellow U.S. Kenya 28 Maternal & Child Health Maternal & Child Heitzinger Health & Child Maternal Hoy-Schulz Kr Health & Child Maternal Nielsen Yana PhD Katie MPH MD, GHES NPGH Fellow U.S. Fellow U.S. Bangladesh Peru 6 30 57

PAGE

COUNTRY

GHF SITE Peru 29

DESIGNATION

GHF Fulbright-Fogarty Student

CONSORTIUM

DEGREE(S)

PhD, MPH MPH PhD, GloCal Fellow U.S. Kenya 12 ADVANCED

NAME

en en MSc PhD, GHES Fellow LMIC India 8 niel MSc DVM, NPGH Fellow LMIC Kenya 27 FIRST

NAME

LAST Ryan Ryan Martha VECD Scholar U.S. India 38

INTEREST

RESEARCH Maternal & Child Health Maternal & Child Puttaswamy Health Maternal & Child Weaver Nave Health Maternal & Child Williams Health Mental Emily Mental Health Tundun PhD, MA MD Health Mental Franz Disease Non-Communicable Shah Hall UJMT Disease, Non-Communicable Lauren Eye Diseases Sobowale Infectious Diseases Other MPH MBChB, NPGH Sapna U.S. Fellow Brian Bailey Kunmi Infectious Diseases Other MD Chivatsi PhD, MA LMIC Fellow VECD Diseases Infectious Other Argentina Morgan Cybulski Diseases Infectious Other Uganda Da Fellow U.S. 18 Deichsel Jim UJMT VECD 32 Africa South Emily VECD MS U.S. Fellow 40 Fellow U.S. MPH Scholar U.S. China India Vietnam GHES NPGH 18 39 41 Scholar U.S. India 7 Other Infectious Diseases Diseases Infectious Other Deshotel Diseases Infectious Other Dupnik Diseases Infectious Other Mike Howard Diseases Infectious Other PhD Kate Ma Diseases Infectious Other Leigh Marlow MD MPH MD, Daphne Mariel UJMT PhD MPH PhD, VECD VECD Fellow U.S. Fellow U.S. Fellow U.S. GHES Peru NPGH Zambia Fellow U.S. Brazil Fellow U.S. 21 41 Brazil 36 Peru 6 29 58

PAGE

COUNTRY

GHF SITE Brazil 36 Kenya 39 39 Kenya Malawi 21

DESIGNATION

GHF Fulnright-Fogarty Stu- dent Fulbright-Fogarty Post- doctoral Scholar Fulbright-Fogarty Stu- dent

CONSORTIUM

DEGREE(S)

ADVANCED

NAME or MPH MD, NPGH Fellow LMIC Peru 30

FIRST

NAME

LAST Kundu Kundu PhD Tecla Mtui-Temu MD, VECD Arti MEng PhD, GloCal Fellow U.S. India 12

INTEREST

RESEARCH Other Infectious Diseases Infectious Diseases Other Mori Infectious Diseases Other Odetunde Nican Juliana MS VECD Other Infectious Diseases Diseases Infectious Other Paploski Diseases Infectious Other Rojas Infectious Diseases, Other Igor Bioengineering Pathobiology, Pediatric Endocrinology, MSc DVM, Rico Nutrition PhD GHES Fellow LMIC GHES Brazil Fellow U.S. 7 Bangladesh 6 Women's Health Women's Health Women's Aharon O'Shea Devora Michele NPGH UJMT Scholar U.S. Peru 28 Women's Health Women's Servin Argentina MD, MPH GloCal U.S. Fellow Mexico 13 59 GHF & FULBRIGHT‐FOGARTY ALUMNI SPEAKERS

PAGE

COUNTRY

Uganda, Uganda, 52 Ghana GHF SITE

DESIGNATION

GHF Alum Uganda 51 51 Fulbright-Fogarty Uganda Alum

GH LMIC Scholar Alum Thailand 51 Alum Scholar GH LMIC oCal U.S. Fellow Alum Panama Panama 48 Alum Fellow U.S. oCal Kenya 50 Alum Fellow oCal U.S. CONSORTIUM GHES U.S. Fellow Alum Ukraine Ukraine 46 Alum Fellow Peru U.S. GHES 48 Alum Fellow GloCal LMIC MMed MMed GloCal Alum Fellow LMIC Uganda 49

MPH GHES LMIC Fellow Alum Kenya Kenya 47 Alum Fellow LMIC GHES MPH c NPGH LMIC Scholar Alum Kenya 52 52 Kenya Alum Scholar LMIC c NPGH DEGREE(S) PhD, MSc MSc PhD, GHES Alum Fellow LMIC Uganda 47

MPH GHES U.S. Fellow Alum Brazil 45 NAME

FIRST Mohammad Mohammad Aminul MSc PhD, GHES Alum Fellow LMIC Bangladesh 46

NAME

LAST

INTEREST

RESEARCH Cancer Love Tim MD VECD LMIC Fellow Alum Ethiopia 53 53 Ethiopia Alum Fellow LMIC 53 Zambia VECD MD Alum Tim Fellow Love Cancer MBChB LMIC PhD Cancer VECD Martha Bojko HIV/Malaria/TB Takondwa MSc Chidumayo HIV/Malaria/TB MBChB, Nitiya MD NP Raul HIV/Malaria/TB Chomchey Martin PhD PhD, Chuquiyauri HIV/Malaria/TB Amanda Gl Fenner HIV/Malaria/TB Damalie K. Iman MBChB, Nakanjako HIV/Malaria/TB MSc MPH, PhD, UJMT MS Videlis Nduba HIV/Malaria/TB NPGH Frankline HIV/Malaria/TB Onchiri Alum Fellow U.S. Pac HIV/Malaria/TB MD Lincoln Wolf HIV/Malaria/TB Hilary Gl Diseases Infectious Other Ballard InfectiousOther Diseases Berman Sarah Infectious Diseases Other Hillary MPH MD, Kazibwe Diseases Infectious Other Openshaw Anne UJMT John MSc MD, Alum Fellow U.S. Peru GHES 50 Alum Fellow U.S. Bangladesh 47 Other Infectious Diseases Infectious Diseases Other Islam 60

PAGE

COUNTRY

GHF SITE

DESIGNATION

GHF

GH LMIC Fellow Alum Peru Peru 52 Alum Fellow GH LMIC CONSORTIUM MPH GHES LMIC Fellow Alum Zimbabwe Zimbabwe 46 Alum Fellow GHES MPH LMIC

BChB, MSc BChB, MSc GloCal Alum Fellow LMIC Kenya 49 DEGREE(S)

NAME

FIRST

NAME

LAST

INTEREST

RESEARCH Neurology Cornejo Mario MD Health & Child Maternal NP Harding Health Maternal & Child McCollum Health Maternal & Child Kasey Mridha Eric Health Maternal & Child Onono Health Maternal & Child MD Malay Tang Mario Health Mental MPH MBBS, MSc Maricianah M Neurology Cornejo GloCal Jennifer Disease Non-Communicable Anand GloCal Chibanda MD, MSCR UJMT Alum U.S. Fellow Disease Non-Communicable Shaikh Alum Scholar U.S. Bangladesh Dixon Shuchi Health Women's Alum U.S. Fellow Bangladesh UJMT MMed, MD, 49 MD Nida Malawi 48 Kalokhe MSc MS, Alum U.S. Fellow 50 Malawi Ameeta GHES MSc MD, VECD 51 Alum Fellow U.S. Alum Scholar U.S. India India VECD Alum Fellow LMIC 45 India 54 53 61